rfhg_149685.1

Basic information about the TSS

---

TSS ID: rfhg_149685.1 Species: human Chr: chr12		Start: 46267361 End: 46267403 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D2553560,EH38E1607819)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000552197.5:-298 AK309410:-298 GeneID: 81539 HGNC/MGI_ID: HGNC:13447 UniProt_ID: F8VX04 Nearer transcript ids and distances:

Gene_name: solute carrier family 38 member 1 Gene_symbol: SLC38A1 Gene_synonyms: ATA1 NAT2 SAT1 SNAT1 Gene_source: HGNC:13447

TATA-Box annotation

---

Distance to TSS:	605
Nearest PromoterID:	NM_001278390
Entrez ID:	81539
Nearest Unigene:	Hs.533770
Nearest Refseq:	NM_030674
Nearest Ensembl:	ENSG00000111371
Gene Name:	solute carrier family 38 member 1
Gene Alias:	ATA1|NAT2|SAT1|SNAT1
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.511628
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SLC38A1 p2@SLC38A1 p3@SLC38A1 p4@SLC38A1 p5@SLC38A1 p6@SLC38A1 p7@SLC38A1 p8@SLC38A1 p9@SLC38A1 p10@SLC38A1
Sample		p1@SLC38A1	p2@SLC38A1	p3@SLC38A1	p4@SLC38A1	p5@SLC38A1	p6@SLC38A1	p7@SLC38A1	p8@SLC38A1	p9@SLC38A1	p10@SLC38A1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	20.84	13.64	1.75	7.01	2.14	1.75	4.87	2.92	1.56	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	22.05	9.31	1.21	6.88	1.42	0.61	1.42	3.03	1.21	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	21.61	12.73	2.70	5.98	2.51	0.77	2.89	2.51	2.12	0.58
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	21.00	18.50	1.46	7.69	1.46	1.66	4.37	3.33	1.87	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	22.05	14.62	1.80	8.55	2.92	1.80	6.07	2.70	1.57	0.90
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	20.35	19.19	1.74	5.81	1.74	1.16	5.43	3.49	1.55	0.58
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	21.57	27.24	1.96	8.06	4.79	4.79	5.01	3.70	2.40	1.31
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	22.04	20.35	2.42	9.45	2.91	2.91	6.78	4.36	2.91	1.45
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	22.87	20.94	1.28	8.33	3.42	1.71	4.70	2.56	2.14	0.64
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	38.83	73.03	8.11	17.39	9.27	3.48	3.48	10.43	5.80	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	42.44	69.53	6.06	19.81	5.26	3.64	4.45	7.68	6.06	1.21
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	39.84	86.60	6.10	21.55	6.50	4.07	6.10	6.91	6.91	2.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	6.13	2.42	1.93	2.10	1.29	1.13	0.48	0.81	2.74	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	5.11	3.16	1.35	1.65	0.60	1.20	1.05	0.75	0.90	1.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	5.49	3.51	1.54	0.88	1.10	1.10	0.44	2.20	1.54	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	5.28	2.26	2.77	2.01	1.26	1.76	0.75	0.75	2.01	1.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	5.24	1.31	2.62	0.44	1.31	1.53	0.87	1.09	1.09	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	3.37	3.37	2.53	0.42	0.42	0.00	0.42	1.69	1.69	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	3.73	1.07	1.07	0.53	0.53	0.53	0.00	1.07	2.13	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	6.02	3.46	1.96	1.35	0.45	0.75	0.60	2.11	1.50	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	5.88	3.07	2.41	1.20	1.87	1.07	0.53	1.34	1.60	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	5.70	2.07	1.90	1.21	1.38	0.52	0.52	1.73	1.38	0.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	5.82	1.94	1.81	1.03	1.29	1.03	0.90	1.42	2.46	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	3.88	2.43	1.21	0.97	0.97	0.73	0.49	1.21	1.46	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	5.68	1.81	1.55	1.81	2.84	1.29	1.03	0.52	1.29	1.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	3.80	0.95	1.58	0.95	0.95	1.27	1.27	1.58	0.32	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	3.30	2.20	3.30	1.10	2.20	0.55	2.20	0.00	1.10	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	7.31	3.54	2.12	1.41	1.41	1.18	0.71	1.65	0.47	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	5.81	1.29	1.45	1.13	0.97	0.65	0.48	0.81	1.29	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	3.98	2.53	1.45	0.36	1.63	0.54	0.72	1.45	1.63	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	4.61	2.72	1.88	1.47	0.84	0.63	0.00	0.84	1.88	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	5.47	3.52	1.95	1.56	2.34	0.78	0.78	2.15	0.98	1.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	3.17	2.53	1.27	0.84	1.48	0.63	0.21	1.06	1.48	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	6.43	2.64	2.31	1.65	1.98	0.49	0.33	0.16	0.99	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	4.30	2.43	2.06	0.75	1.12	1.50	0.37	0.75	1.31	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	6.13	2.87	1.53	0.57	1.53	0.38	0.77	2.49	0.96	0.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	3.47	2.86	1.84	2.04	0.61	0.20	1.02	0.61	1.02	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	5.04	1.81	1.41	0.81	2.62	1.41	0.60	1.21	0.81	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	4.32	3.24	2.43	1.35	0.81	1.62	0.81	1.08	0.81	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	3.36	1.68	2.40	0.72	0.24	0.24	0.24	0.72	1.20	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	2.82	2.35	1.18	0.71	0.47	1.18	0.47	1.18	0.24	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	4.68	2.64	0.88	0.73	1.17	0.29	0.44	0.44	2.20	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	4.85	2.11	1.90	1.05	1.05	0.63	0.21	1.27	1.05	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	3.32	2.97	1.75	1.40	1.40	0.17	0.52	2.10	0.70	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	3.21	3.41	0.80	0.20	1.20	0.80	1.41	2.41	0.60	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	4.89	3.02	1.16	0.70	0.93	0.47	0.47	0.93	0.23	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	2.88	2.88	0.72	0.24	0.72	0.24	0.24	0.96	0.48	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	3.58	2.68	1.79	0.89	1.19	0.60	0.60	1.49	0.60	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	2.39	1.68	0.48	0.48	1.20	0.96	0.72	1.20	0.48	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	2.83	4.85	1.01	1.21	1.62	0.00	0.40	1.21	1.21	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	4.51	3.07	1.43	0.00	1.84	0.41	0.20	2.25	0.20	1.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	3.78	4.45	1.11	1.11	0.67	0.22	0.22	1.56	0.89	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	0.00	0.00	13.99	0.00	0.00	0.00	0.00	13.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	3.55	3.90	0.71	1.06	0.35	0.71	0.71	1.77	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	3.65	0.99	0.66	0.66	0.99	0.33	0.00	1.99	0.99	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	6.71	1.68	1.68	2.52	0.84	3.36	0.00	0.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	3.67	1.38	0.92	1.84	0.92	0.92	0.00	0.00	0.00	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	4.21	6.16	0.00	1.30	1.62	0.97	0.32	3.57	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	4.50	3.53	0.96	1.28	0.64	0.32	0.00	1.93	0.32	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	7.54	3.14	1.89	1.89	2.20	2.51	0.63	0.31	0.63	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	3.53	13.40	3.53	0.00	3.53	0.71	0.71	4.94	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	4.49	7.85	1.12	0.56	2.80	2.80	0.00	5.05	0.56	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	17.52	3.98	5.57	3.98	3.18	1.59	0.80	1.59	1.59	1.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	12.23	7.81	1.70	2.72	4.08	3.06	0.00	3.40	1.36	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	4.22	15.92	4.55	1.30	1.30	2.60	0.00	5.85	0.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	8.52	11.00	4.26	2.13	4.26	2.84	1.06	4.26	1.42	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	0.00	0.00	32.33	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	39.49	7.90	15.79	0.00	7.90	0.00	0.00	0.00	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	4.39	4.88	0.49	1.46	0.49	0.98	0.00	4.88	0.98	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	7.93	6.94	1.49	2.48	1.49	0.50	0.00	2.48	1.98	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	4.69	4.22	1.88	0.94	0.47	0.94	0.47	0.94	0.47	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	9.60	4.64	2.65	0.33	1.32	1.99	0.66	1.66	0.99	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	5.26	4.02	1.24	1.55	2.47	1.55	0.31	3.09	0.93	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	2.75	4.28	1.83	1.53	2.45	1.53	0.00	2.45	0.61	0.61
Adipocyte - breast, donor1	11376-118A8	19.16	16.63	20.59	6.97	8.24	5.07	6.97	3.17	3.01	2.38
Adipocyte - breast, donor2	11327-117E4	12.19	12.99	10.59	4.97	5.29	4.49	2.25	4.17	2.73	0.32
Adipocyte - omental, donor1	11473-119C6	27.74	21.25	44.66	14.00	10.05	4.71	12.34	6.23	3.31	1.40
Adipocyte - omental, donor2	11474-119C7	14.95	11.96	14.20	2.24	3.74	1.49	3.74	3.74	1.49	0.00
Adipocyte - omental, donor3	11475-119C8	16.75	13.06	14.07	4.02	2.68	0.67	2.68	2.68	1.00	0.33
Adipocyte - perirenal, donor1	11476-119C9	17.23	7.02	16.59	5.74	3.19	1.28	2.55	5.10	1.28	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	2.20	0.00	0.00	0.00	1.10	0.00	0.00	0.00	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	2.71	1.81	1.35	0.45	0.45	0.90	0.00	0.45	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	0.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	2.35	1.76	0.20	0.78	0.00	0.78	0.00	1.17	0.59	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	2.32	2.57	0.00	0.51	0.00	0.26	0.00	0.51	0.26	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	2.79	2.51	0.28	0.84	0.56	0.56	0.00	0.84	1.12	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	2.35	1.76	0.59	1.76	0.00	0.00	0.00	0.00	0.59	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	1.21	0.24	0.24	0.24	0.08	0.08	0.08	0.72	0.24	0.32
Adipocyte differentiation, day08, donor2	13023-139D8	0.65	0.65	0.65	1.29	0.00	0.97	0.00	0.32	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	4.27	1.07	0.00	0.53	0.00	0.00	0.53	0.00	1.07	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	1.67	0.56	0.56	1.67	0.00	0.00	0.00	1.11	0.00	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	2.50	0.83	0.42	0.00	0.00	0.42	0.00	1.66	0.42	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	1.00	1.00	0.00	1.26	0.75	0.00	0.50	0.00	1.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	1.64	0.65	0.33	0.65	0.00	0.00	0.33	0.33	0.65	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	1.83	0.00	0.61	0.30	0.30	0.00	0.00	0.91	0.00	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	5.97	7.29	0.66	1.77	1.55	2.43	0.66	2.21	0.88	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	3.59	3.23	0.36	0.36	1.43	0.72	1.43	1.79	0.36	1.43
Alveolar Epithelial Cells, donor3	11671-122G6	0.00	1.20	0.00	1.20	0.00	0.00	0.00	0.00	0.00	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	17.81	17.45	11.87	7.38	8.10	5.22	3.60	3.60	3.06	0.72
Amniotic Epithelial Cells, donor2	11613-122A2	10.04	15.06	3.35	5.02	0.00	1.67	1.67	1.67	1.67	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	10.07	7.40	1.85	3.08	2.05	1.64	2.88	1.85	1.03	0.82
Anulus Pulposus Cell, donor1	11248-116E6	2.52	3.09	1.37	1.72	0.80	0.57	0.23	1.95	1.60	1.60
Anulus Pulposus Cell, donor2	11463-119B5	1.71	1.71	1.47	0.24	0.73	0.49	0.49	1.71	0.98	3.18
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	2.70	1.80	0.00	0.90	0.90	0.90	0.45	1.35	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	5.64	3.04	1.74	2.17	0.43	0.43	0.43	1.30	0.87	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	2.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	4.18	4.18	0.60	2.09	1.20	1.20	0.60	1.49	0.30	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	3.79	1.26	1.26	0.00	0.00	0.00	0.00	3.79	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	1.32	1.98	0.00	0.00	0.00	0.00	0.00	1.32	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	2.60	2.60	0.00	0.97	0.00	0.32	0.32	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	3.40	1.46	0.00	0.49	0.00	0.97	0.00	0.49	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	3.56	4.16	0.59	0.00	1.19	1.19	0.00	1.19	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	4.14	3.39	0.75	0.75	1.13	0.75	0.38	0.38	0.38	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	5.08	0.73	0.00	1.45	0.00	1.45	1.45	2.18	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	5.02	2.51	0.00	1.25	0.00	0.00	0.00	1.25	0.00	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	4.28	3.46	0.66	1.32	0.49	0.99	0.82	1.48	0.66	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	4.09	4.09	0.00	1.36	1.36	0.00	1.36	1.36	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	1.66	2.87	0.15	0.60	0.45	0.90	0.30	0.90	0.30	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	2.68	2.68	0.00	1.07	0.00	0.00	0.54	2.14	2.14	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	3.02	2.65	0.19	0.38	0.57	0.76	0.19	1.51	0.38	0.94
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	2.41	3.21	0.80	1.34	1.07	0.80	0.27	1.34	0.27	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	0.98	0.98	0.98	1.95	0.00	0.00	1.95	1.95	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	2.32	3.15	1.16	0.66	0.66	0.83	0.00	1.49	0.50	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	2.40	3.60	0.00	0.00	0.00	2.40	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	3.54	0.00	3.54	0.00	3.54	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	2.92	3.26	0.51	0.51	0.34	0.34	0.17	0.86	0.34	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	0.00	4.19	0.00	0.00	0.00	0.00	0.00	0.00	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	3.40	1.46	1.46	0.49	0.00	0.49	1.46	0.00	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	4.17	1.14	0.76	0.76	0.00	0.76	0.38	1.52	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	1.21	2.42	0.00	0.00	1.21	0.00	0.00	1.21	2.42	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	3.42	4.56	1.14	0.00	0.00	0.57	0.57	0.00	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	4.28	1.92	0.64	0.64	0.86	0.64	0.64	1.50	0.43	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	3.10	2.32	0.26	1.81	0.00	0.52	0.26	1.55	0.26	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	2.82	2.82	0.47	1.41	0.47	0.00	0.00	1.41	0.00	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	3.54	2.57	0.64	1.61	0.64	0.64	0.32	1.29	0.32	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	3.57	2.14	0.00	0.71	0.00	0.00	0.71	0.71	0.00	2.85
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	0.58	1.75	0.58	1.75	0.58	1.75	1.17	0.58	0.00	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	2.71	2.41	0.00	0.30	0.60	0.90	0.30	1.20	0.00	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	3.56	2.38	0.00	1.19	0.00	3.56	0.00	2.38	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	5.59	1.53	0.00	0.51	0.51	0.00	0.00	0.00	1.53	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	1.27	2.04	0.51	1.27	1.02	0.51	0.25	1.53	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	1.27	1.91	0.64	1.27	0.00	0.64	0.64	0.64	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	5.18	3.45	0.00	3.88	0.00	0.43	0.43	2.16	0.00	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	1.69	2.12	0.00	0.85	0.64	0.64	0.21	0.64	1.48	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	1.74	3.19	0.58	0.58	0.58	0.29	0.29	0.87	0.29	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	1.89	1.89	0.00	0.00	0.00	0.94	0.94	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	2.71	2.71	0.34	0.85	0.00	1.02	0.68	0.34	1.53	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	0.00	2.32	0.00	2.32	2.32	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	0.00	2.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	2.57	3.22	0.21	0.21	1.07	0.86	0.00	0.64	0.86	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	3.01	3.01	0.60	0.60	0.00	0.00	0.60	1.20	0.00	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	3.64	1.46	1.46	1.46	1.46	0.73	1.46	0.73	0.00	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	5.52	3.68	0.46	1.38	0.92	0.92	0.46	0.92	0.46	0.92
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	5.10	2.55	0.00	0.00	2.55	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	2.80	3.31	0.76	1.78	1.27	1.78	0.51	1.02	0.25	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	3.10	3.92	0.41	1.03	0.62	0.41	0.21	0.62	0.21	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	2.45	2.75	1.53	0.31	0.92	1.22	0.31	1.84	0.31	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	3.82	5.26	0.48	0.00	1.43	0.96	0.48	0.48	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	2.88	3.10	0.67	1.33	0.22	0.22	0.22	1.33	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	6.10	3.05	0.00	1.53	0.00	0.00	0.00	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	2.77	3.32	0.00	0.00	0.55	1.66	0.55	0.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	2.91	2.12	0.26	0.26	0.00	0.53	0.26	2.12	0.26	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	1.82	2.91	0.00	0.00	0.36	0.73	0.36	1.45	0.00	0.36
Astrocyte - cerebellum, donor1	11500-119F6	2.09	2.46	1.23	0.37	1.35	1.11	0.37	0.98	0.49	0.74
Astrocyte - cerebellum, donor2	11580-120F5	1.71	1.88	0.51	0.00	1.03	0.34	0.00	1.71	0.86	1.37
Astrocyte - cerebellum, donor3	11661-122F5	1.26	2.94	1.47	0.21	0.84	1.05	0.63	1.26	1.26	1.05
Astrocyte - cerebral cortex, donor1	11235-116D2	6.27	3.49	1.74	1.74	0.70	0.35	0.35	1.05	1.39	1.05
Astrocyte - cerebral cortex, donor2	11316-117D2	8.90	5.01	2.26	2.43	2.10	1.62	0.32	1.29	2.26	3.07
Astrocyte - cerebral cortex, donor3	11392-118C6	15.81	6.56	4.92	2.98	3.28	1.34	1.79	3.28	2.98	2.83
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	49.89	29.13	4.13	5.62	4.24	14.34	13.07	11.58	3.33	2.98
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	45.35	31.70	5.14	7.64	6.51	14.16	14.53	10.15	4.76	3.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	41.88	30.04	3.53	6.83	5.01	12.97	12.63	12.63	3.76	3.41
Basophils, donor1	12241-129G9	20.40	9.15	0.78	3.66	0.26	0.52	7.85	2.09	1.83	0.26
Basophils, donor2	12242-129H1	88.03	22.73	6.13	18.76	3.25	5.41	57.73	3.61	11.18	3.25
Basophils, donor3	12243-129H2	22.64	7.50	1.18	3.67	0.88	1.03	11.91	2.94	2.50	0.59
Bronchial Epithelial Cell, donor1	11511-119G8	3.67	3.02	1.29	1.72	0.86	0.43	1.08	0.22	0.86	0.43
Bronchial Epithelial Cell, donor2	11591-120G7	1.83	2.74	1.37	0.00	1.83	0.00	0.00	1.83	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	28.69	21.52	7.17	7.17	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	14.44	10.67	3.14	2.51	1.26	1.26	3.77	2.51	1.88	1.88
Bronchial Epithelial Cell, donor5	11457-119A8	11.23	9.77	3.74	3.74	5.82	2.91	0.83	2.29	1.46	0.62
Bronchial Epithelial Cell, donor6	11461-119B3	18.19	20.27	5.99	3.91	5.07	3.91	1.61	2.76	2.99	1.15
Bronchial Epithelial Cell, donor7	11769-123I5	22.13	8.10	1.98	3.42	3.78	2.88	2.34	3.06	4.14	0.90
Burkitt's lymphoma cell line:DAUDI	10422-106C8	42.97	31.02	2.99	9.17	2.16	7.42	6.29	6.80	8.14	6.80
Burkitt's lymphoma cell line:RAJI	10476-106I8	50.77	34.47	5.36	9.55	7.69	13.97	13.28	11.18	4.89	2.56
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	17.59	5.44	0.96	7.67	0.96	1.60	1.60	3.52	3.84	1.28
CD133+ stem cells - cord blood derived, pool1	12223-129E9	82.74	0.00	10.34	10.34	0.00	0.00	0.00	10.34	0.00	10.34
CD14+ Monocytes, donor1	11224-116B9	24.80	5.64	0.56	5.07	0.56	0.56	4.51	1.13	2.25	0.56
CD14+ Monocytes, donor2	11305-117B9	23.39	6.50	1.30	5.20	0.37	0.74	8.91	0.93	2.60	1.48
CD14+ Monocytes, donor3	11381-118B4	30.74	7.24	0.66	5.49	1.54	0.22	10.54	1.54	3.29	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	3.11	0.57	0.00	0.28	0.00	0.00	0.28	0.28	0.28	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	12.13	3.03	0.76	5.31	0.76	0.00	1.90	0.76	0.76	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	4.93	0.99	0.33	0.99	1.31	0.33	0.00	0.00	0.99	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	5.78	2.89	0.87	2.31	0.58	0.72	2.02	0.14	0.14	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	10.26	5.13	1.21	3.32	2.11	0.91	1.51	0.60	0.60	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	6.63	2.61	0.71	1.18	0.47	0.24	1.18	0.47	0.47	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	6.36	8.87	0.84	2.34	1.34	1.51	2.68	0.67	0.50	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	13.80	12.97	3.31	3.59	1.38	2.76	3.86	1.66	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	10.66	11.65	1.49	4.96	2.73	2.23	3.72	0.50	0.25	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	6.27	10.38	0.78	0.78	0.59	1.57	0.78	0.59	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	12.29	9.79	1.42	4.10	0.71	1.96	2.67	1.60	0.89	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	6.96	6.75	1.09	2.39	0.87	0.87	2.39	0.65	0.44	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	2.81	3.98	0.23	1.64	0.47	0.70	1.17	0.47	0.23	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	9.50	4.22	2.11	2.11	0.53	1.58	2.64	1.58	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	4.44	3.33	0.00	2.22	0.00	1.11	1.11	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	5.95	5.95	1.19	2.53	1.78	0.74	1.78	0.00	0.00	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	12.57	10.18	2.39	3.59	2.00	1.40	3.59	0.40	0.40	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	8.54	6.25	2.71	5.00	1.46	0.83	1.46	0.83	0.42	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	6.86	7.09	1.60	2.29	1.37	0.69	1.83	0.23	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	7.92	10.63	2.04	4.98	2.49	0.90	3.85	2.04	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	6.55	3.93	0.87	2.62	0.87	0.87	0.87	0.00	0.44	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	4.30	4.30	0.54	2.15	0.54	0.27	2.42	0.27	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	8.03	4.54	2.09	2.44	1.92	1.57	2.97	0.35	0.35	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	5.47	3.79	0.42	1.68	2.52	1.26	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	6.25	4.23	0.18	1.47	0.92	1.10	0.92	1.10	0.00	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	10.92	10.57	0.35	3.87	1.76	1.06	1.76	1.76	1.06	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	10.53	6.58	0.44	3.07	1.32	0.00	0.88	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	5.23	9.76	0.17	2.44	0.87	1.22	1.92	0.52	0.17	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	13.01	11.15	0.74	4.46	1.49	1.12	2.60	0.74	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	10.13	10.35	0.43	4.53	0.86	1.08	2.16	1.29	0.00	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	6.55	4.09	0.41	2.46	0.00	0.41	1.23	0.41	1.23	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	15.07	7.65	0.70	5.33	1.16	1.62	1.85	1.39	0.46	0.46
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	6.03	6.26	0.00	2.78	0.46	0.46	1.16	1.86	0.23	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	0.22	0.00	0.00	0.22	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	0.23	0.23	0.00	0.00	0.00	0.00	0.23	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	0.22	0.00	0.00	0.22	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	0.62	0.31	0.00	0.31	0.00	0.00	0.16	0.16	0.16	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	0.70	0.35	0.00	0.17	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	0.22	0.00	0.00	0.00	0.00	0.00	0.45	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	0.00	0.00	0.00	0.22	0.00	0.00	0.22	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	93.49	14.23	4.06	4.06	2.03	8.13	12.19	0.00	8.13	4.06
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	105.76	11.53	4.07	13.56	4.07	6.10	14.92	3.39	12.20	2.71
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	122.20	7.25	1.04	17.61	6.21	2.07	12.43	2.07	9.32	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	116.20	10.66	2.13	14.93	2.67	6.40	22.39	4.26	12.26	2.13
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	132.41	11.79	2.14	9.11	0.54	1.07	22.51	3.75	5.36	2.14
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	94.76	7.72	1.40	10.53	1.40	3.51	21.06	1.40	5.62	1.40
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	123.93	13.33	1.57	17.26	0.78	0.78	16.47	0.78	5.49	3.14
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	126.56	13.18	2.64	11.86	2.64	2.64	23.73	3.95	3.95	2.64
CD19+ B Cells, donor1	11544-120B5	126.57	31.23	2.47	10.68	0.82	4.11	26.30	7.40	12.33	1.64
CD19+ B Cells, donor2	11624-122B4	97.93	22.49	2.90	10.16	3.63	1.45	25.39	7.25	2.90	0.00
CD19+ B Cells, donor3	11705-123B4	90.87	22.21	3.53	8.58	1.51	4.04	24.23	5.05	4.04	1.51
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	0.40	0.00	0.00	0.00	0.00	0.40	0.00	0.00	0.40	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	2.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	10.04	4.02	1.00	7.03	3.01	0.00	4.02	1.00	2.01	1.00
CD34+ Progenitors, donor2	11625-122B5	61.24	13.48	4.49	10.67	2.25	0.56	21.91	2.25	6.74	2.25
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	20.29	6.01	1.13	3.76	2.25	1.13	2.25	1.88	6.76	3.01
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	13.30	4.96	2.25	6.09	2.48	2.25	2.03	1.35	7.22	2.71
CD4+ T Cells, donor1	11225-116C1	236.73	13.21	7.14	55.34	3.21	2.14	53.56	6.07	34.99	7.50
CD4+ T Cells, donor2	11306-117C1	192.89	12.86	6.74	41.64	3.06	1.22	66.75	4.90	18.98	5.51
CD4+ T Cells, donor3	11382-118B5	173.85	14.64	6.10	39.65	2.13	3.96	59.17	4.27	17.08	6.10
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	89.08	6.38	7.40	15.31	5.87	4.34	14.29	2.30	5.10	1.79
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	67.38	8.31	11.01	18.42	8.98	2.25	13.03	1.57	5.84	3.82
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	63.82	7.47	11.50	17.25	6.90	2.87	14.66	2.59	5.17	2.87
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	154.08	11.38	4.27	37.93	2.84	1.90	36.51	4.74	26.08	7.11
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	133.44	8.43	11.24	37.93	4.92	0.70	33.71	4.92	18.96	6.32
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	161.51	13.18	0.00	26.37	3.30	0.00	16.48	0.00	23.07	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	59.11	15.17	8.38	16.62	6.65	4.77	16.62	5.93	3.90	2.02
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	43.72	6.61	8.81	9.32	4.91	2.37	11.35	3.56	4.41	1.36
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	50.30	8.06	8.38	10.16	5.80	2.58	12.09	2.26	4.35	1.61
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	96.38	13.00	4.48	25.10	4.48	2.69	33.17	3.14	10.76	1.79
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	105.86	8.39	10.48	24.11	8.04	2.10	23.06	3.84	10.13	3.14
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	118.79	13.20	14.96	33.00	7.92	4.40	26.84	7.04	17.60	3.52
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	61.56	12.23	7.17	20.24	5.06	6.32	23.19	2.53	6.75	2.53
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	39.68	7.27	7.90	8.31	6.03	2.08	11.84	3.32	3.95	0.83
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	41.10	9.69	8.35	7.68	4.34	2.34	17.37	3.34	1.34	3.34
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	146.03	7.89	4.35	51.67	1.63	3.26	20.67	1.90	29.64	8.43
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	181.15	4.29	8.04	53.59	9.11	3.22	24.65	2.14	21.44	10.18
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	127.32	5.38	10.76	32.28	3.59	0.00	23.31	0.00	25.11	5.38
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	69.16	13.54	12.98	17.80	7.23	6.49	19.84	2.60	5.75	1.48
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	58.92	8.66	10.40	12.78	4.55	2.60	14.73	1.73	3.47	0.87
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	56.32	7.78	11.35	14.50	6.51	3.99	16.39	2.94	4.41	1.26
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	111.74	8.60	3.03	31.35	8.09	6.07	36.40	4.55	16.68	5.56
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	123.04	6.07	4.77	30.33	5.63	2.17	38.99	2.17	15.60	3.03
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	152.97	16.56	17.43	35.74	9.15	2.18	26.58	3.49	18.74	5.23
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	153.41	17.82	6.43	38.10	1.98	2.47	14.35	3.96	23.26	3.96
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	123.71	12.92	7.39	31.39	4.62	3.69	12.00	6.46	17.54	6.46
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	107.48	15.35	1.40	40.48	0.00	5.58	11.17	6.98	23.73	4.19
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	189.97	15.51	3.32	44.59	4.98	4.98	9.97	4.98	30.19	8.86
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	193.37	19.39	3.44	43.43	5.64	3.93	13.74	2.70	27.24	10.80
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	121.66	16.94	6.16	44.66	6.16	9.24	10.78	0.00	26.18	12.32
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	136.08	15.04	9.31	39.03	4.66	3.58	15.04	3.58	21.85	6.45
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	132.96	13.85	1.38	33.24	5.54	5.54	15.23	6.92	23.54	4.15
CD8+ T Cells, donor1	11226-116C2	219.03	36.01	11.46	47.47	6.55	4.26	95.60	8.18	24.55	4.26
CD8+ T Cells, donor2	11307-117C2	172.32	41.30	11.26	29.66	5.26	4.88	106.62	4.88	15.02	2.63
CD8+ T Cells, donor3	11383-118B6	212.85	28.53	8.08	34.59	8.08	4.04	74.23	8.58	28.53	3.28
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	12.39	11.93	3.44	3.44	3.44	8.49	2.06	3.21	1.38	1.15
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	8.63	12.46	1.68	2.64	2.40	9.11	3.35	2.16	1.68	0.96
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	7.11	10.40	3.01	2.19	4.10	10.94	4.10	2.46	0.82	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	15.31	15.61	1.80	3.00	5.10	9.61	4.20	4.20	0.60	1.80
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	8.64	11.28	2.64	2.88	2.88	6.48	2.40	2.64	0.48	1.20
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	15.69	11.60	2.05	2.50	3.64	7.96	3.64	2.27	1.82	1.82
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	12.39	10.86	2.39	2.82	3.26	8.91	3.48	2.39	1.30	1.09
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	10.00	5.79	2.90	2.11	3.68	8.16	4.47	3.95	0.79	2.11
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	11.73	7.97	2.81	2.35	4.69	7.74	2.58	3.05	1.41	0.94
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	13.58	13.89	3.32	3.92	4.23	14.79	3.32	4.23	1.51	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	11.04	9.30	3.20	3.20	6.97	11.91	3.78	4.65	0.58	1.16
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	15.72	15.72	3.46	2.66	5.86	11.19	2.93	2.66	1.87	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	14.88	21.89	5.25	4.82	3.94	10.07	2.63	5.25	0.44	1.75
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	15.03	20.95	2.73	2.73	3.64	6.83	3.19	1.82	1.37	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	16.41	30.58	0.75	2.98	1.49	12.68	3.73	8.20	2.24	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	8.64	12.25	1.44	1.80	4.32	8.28	2.88	2.16	0.72	1.44
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	14.96	11.22	2.88	2.59	5.47	9.49	1.15	2.30	2.01	1.73
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	10.61	9.19	1.65	1.18	2.83	6.13	2.83	3.30	0.47	1.18
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	16.80	12.36	5.39	5.07	4.12	12.36	4.12	3.17	1.27	1.90
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	11.99	17.22	1.54	4.00	5.54	10.46	5.84	2.46	1.54	1.23
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	16.67	13.46	4.49	3.53	4.49	8.01	2.56	5.13	0.96	1.28
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	14.92	18.36	1.91	6.12	4.97	10.33	4.21	3.44	0.38	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	17.73	11.03	3.55	4.34	2.76	11.03	0.79	5.52	0.79	0.79
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	10.59	15.88	3.03	3.03	11.35	13.62	0.76	2.27	0.76	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	21.68	24.09	0.80	4.82	4.01	8.03	0.80	5.62	0.80	1.61
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	20.98	20.28	2.10	9.79	4.20	6.99	3.50	11.89	1.40	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	27.05	19.03	3.01	4.01	3.01	14.02	4.01	8.01	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	0.99	2.96	0.99	0.99	0.49	0.49	0.00	1.48	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	8.42	17.36	9.68	1.58	5.16	6.00	0.63	3.26	2.63	0.95
Chondrocyte - de diff, donor1	11261-116G1	11.09	7.28	7.28	1.04	2.43	0.35	0.69	4.51	1.73	2.77
Chondrocyte - de diff, donor2	11338-117F6	3.55	7.11	1.78	1.78	3.20	2.13	1.07	1.78	2.13	0.36
Chondrocyte - de diff, donor3	11410-118E6	7.74	5.35	5.80	3.19	3.19	0.57	1.37	2.28	3.07	2.39
Chondrocyte - re diff, donor2	11339-117F7	6.27	4.48	4.48	3.58	6.27	0.90	0.00	2.69	0.90	0.90
Chondrocyte - re diff, donor3	11411-118E7	5.26	5.26	2.02	0.40	2.43	1.21	0.00	1.21	0.00	2.02
Ciliary Epithelial Cells, donor1	11242-116D9	11.02	7.12	2.98	1.03	3.21	3.79	2.87	3.90	2.18	2.41
Ciliary Epithelial Cells, donor2	11323-117D9	6.20	7.91	4.06	1.28	2.78	1.07	1.71	2.99	1.92	2.35
Ciliary Epithelial Cells, donor3	11399-118D4	11.95	6.64	6.28	2.04	4.16	2.92	2.74	4.25	3.27	2.39
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	11.65	1.83	1.28	3.39	0.55	0.46	1.38	0.64	1.28	3.85
Corneal Epithelial Cells, donor1	11526-119I5	3.51	4.39	0.66	0.88	0.66	0.44	0.44	0.88	1.76	0.66
Corneal Epithelial Cells, donor2	11606-120I4	12.51	5.69	1.14	3.41	1.14	0.00	2.28	1.14	2.28	1.14
Corneal Epithelial Cells, donor3	11687-122I4	8.69	4.60	2.30	2.30	2.30	1.28	0.26	1.79	1.79	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	0.66	0.00	0.00	0.17	0.00	0.00	0.00	0.00	0.17	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	0.63	0.00	0.32	0.32	0.00	0.00	0.00	0.00	0.32	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	0.22	0.11	0.00	0.00	0.22	0.00	0.00	0.00	0.11	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	113.42	4.44	1.71	38.95	0.68	0.34	39.97	3.07	44.07	19.82
Dendritic Cells - plasmacytoid, donor2	11309-117C4	88.14	5.22	0.65	30.68	0.65	0.65	23.50	2.61	37.87	13.06
Dendritic Cells - plasmacytoid, donor3	11385-118B8	129.70	3.39	2.90	29.52	0.97	0.00	24.20	3.87	32.91	24.68
Endothelial Cells - Aortic, donor0	11207-116A1	8.84	22.51	5.67	3.17	8.34	9.17	2.33	4.00	2.17	1.50
Endothelial Cells - Aortic, donor1	11263-116G3	5.87	7.04	11.74	1.17	6.45	0.59	0.59	2.35	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	3.68	6.50	11.31	1.13	5.66	0.57	0.85	1.13	1.41	0.85
Endothelial Cells - Aortic, donor3	11412-118E8	3.93	7.08	12.58	2.36	2.36	0.39	0.39	1.97	0.00	1.18
Endothelial Cells - Artery, donor1	11264-116G4	4.65	13.67	2.91	1.45	1.75	3.78	2.04	2.33	1.16	0.87
Endothelial Cells - Artery, donor2	11341-117F9	8.94	25.65	4.00	2.82	6.12	6.35	2.12	2.82	2.59	1.65
Endothelial Cells - Artery, donor3	11413-118E9	5.96	9.12	7.71	1.40	3.33	1.93	1.05	1.75	1.23	1.75
Endothelial Cells - Lymphatic, donor1	11236-116D3	13.52	13.52	20.17	2.44	8.42	5.10	4.43	3.10	3.55	0.89
Endothelial Cells - Lymphatic, donor2	11317-117D3	17.95	20.39	21.60	3.04	7.00	4.26	4.56	6.09	5.78	2.43
Endothelial Cells - Lymphatic, donor3	11393-118C7	27.91	37.21	18.61	7.89	8.46	6.20	7.61	6.48	3.10	2.26
Endothelial Cells - Microvascular, donor1	11265-116G5	8.32	21.99	5.35	1.19	7.13	6.54	5.94	1.78	1.78	1.49
Endothelial Cells - Microvascular, donor2	11342-117G1	6.77	13.54	12.50	2.08	5.73	2.08	2.60	0.00	2.08	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	8.51	10.63	4.68	2.55	2.55	1.42	3.54	1.56	2.84	0.43
Endothelial Cells - Thoracic, donor1	11266-116G6	13.60	30.41	32.81	5.20	18.81	5.60	4.40	5.60	2.00	2.40
Endothelial Cells - Thoracic, donor2	11343-117G2	4.19	8.39	3.67	1.05	3.67	0.00	0.52	1.57	0.52	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	11.80	12.55	21.74	2.61	10.93	3.11	1.99	6.21	2.11	2.98
Endothelial Cells - Umbilical vein, donor2	11324-117E1	5.87	4.78	5.21	1.52	4.78	1.52	0.22	4.78	0.65	0.87
Endothelial Cells - Umbilical vein, donor3	11400-118D5	10.75	26.14	3.42	1.71	3.54	6.72	2.08	5.37	3.30	2.08
Endothelial Cells - Vein, donor1	11267-116G7	6.83	11.38	5.69	0.00	2.28	2.28	0.00	1.14	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	4.19	13.97	2.10	1.40	2.10	2.10	1.40	2.10	0.00	0.70
Endothelial Cells - Vein, donor3	11416-118F3	5.81	8.32	12.56	1.88	4.40	1.10	2.04	2.51	0.63	1.10
Eosinophils, donor1	12244-129H3	228.70	60.99	0.00	60.99	0.00	0.00	60.99	0.00	30.49	0.00
Eosinophils, donor2	12245-129H4	49.51	3.30	0.00	14.85	1.65	0.00	29.70	1.65	4.95	0.00
Eosinophils, donor3	12246-129H5	53.50	7.13	3.57	14.27	0.00	0.00	10.70	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	4.64	3.66	0.98	0.73	1.47	1.71	0.49	0.73	2.20	0.73
Esophageal Epithelial Cells, donor2	11587-120G3	6.24	2.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	32.54	0.00	0.00	16.27	0.00	0.00	0.00	0.00	16.27
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	14.37	20.53	9.03	1.23	7.80	6.16	2.05	4.93	3.28	1.23
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	5.04	5.04	4.05	1.53	1.53	0.88	1.97	1.64	0.88	0.44
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	6.07	3.03	3.68	2.49	1.41	1.52	1.52	0.11	1.30	1.41
Fibroblast - Aortic Adventitial, donor1	11245-116E3	14.19	24.98	9.94	5.46	9.22	11.76	6.06	4.37	2.43	2.18
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	13.78	43.40	27.98	5.46	12.83	6.14	4.37	7.78	1.50	2.18
Fibroblast - Aortic Adventitial, donor2	11326-117E3	9.39	10.34	10.55	3.16	4.32	1.27	1.90	2.95	1.37	1.16
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	26.35	60.34	86.69	3.69	41.37	13.96	6.32	6.85	3.16	1.05
Fibroblast - Aortic Adventitial, donor3	11401-118D6	12.62	8.97	9.63	2.99	7.31	4.65	3.99	1.33	0.66	1.33
Fibroblast - Cardiac, donor1	11268-116G8	8.62	8.17	6.80	2.27	5.90	2.27	0.91	4.08	2.72	1.36
Fibroblast - Cardiac, donor2	11345-117G4	8.34	19.71	3.79	4.55	3.03	3.79	1.52	4.55	1.52	0.00
Fibroblast - Cardiac, donor3	11417-118F4	8.52	11.99	1.26	1.10	2.52	2.68	1.10	1.89	1.10	0.32
Fibroblast - Cardiac, donor4	11452-119A3	3.33	5.76	2.73	0.61	3.33	2.12	0.61	2.42	0.91	1.21
Fibroblast - Cardiac, donor5	11456-119A7	16.37	30.46	11.68	3.30	10.79	5.84	1.65	4.82	2.28	1.02
Fibroblast - Cardiac, donor6	11460-119B2	5.76	11.82	6.22	0.61	2.73	2.73	1.21	1.97	0.61	0.76
Fibroblast - Choroid Plexus, donor1	11492-119E7	3.08	2.55	1.61	0.80	1.88	0.94	0.27	1.07	1.61	1.21
Fibroblast - Choroid Plexus, donor2	11572-120E6	0.43	2.59	0.86	0.43	0.86	1.29	0.43	1.29	0.43	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	1.46	11.72	2.93	2.93	0.00	1.46	0.00	2.93	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	4.84	27.68	10.38	2.31	7.84	4.15	0.00	4.61	1.15	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	5.77	11.70	16.62	3.22	4.58	1.87	0.68	7.63	4.24	4.75
Fibroblast - Dermal, donor1	11269-116G9	8.69	12.21	3.29	2.11	3.29	3.05	1.17	1.41	2.35	0.70
Fibroblast - Dermal, donor2	11346-117G5	6.60	8.02	3.77	2.83	3.77	3.77	0.47	0.94	0.47	0.47
Fibroblast - Dermal, donor3	11418-118F5	7.37	7.62	0.73	1.21	2.18	4.71	0.73	1.21	1.57	0.60
Fibroblast - Dermal, donor4	11450-119A1	10.29	16.62	4.07	1.36	5.65	3.39	1.24	3.73	1.36	1.47
Fibroblast - Dermal, donor5	11454-119A5	7.85	15.70	4.01	1.92	4.19	2.62	0.52	2.79	1.40	1.22
Fibroblast - Dermal, donor6	11458-119A9	5.36	8.28	3.57	1.46	4.22	1.30	0.49	2.92	1.62	0.81
Fibroblast - Gingival, donor1	11237-116D4	7.50	8.12	1.46	3.12	3.96	6.87	1.04	2.08	2.29	1.46
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	15.98	19.39	13.10	5.76	5.76	8.65	3.14	2.10	2.62	2.10
Fibroblast - Gingival, donor2	11318-117D4	9.22	11.07	8.83	2.64	7.64	3.56	1.45	3.56	2.24	3.16
Fibroblast - Gingival, donor3	11394-118C8	20.79	26.20	3.38	5.41	6.28	10.54	2.13	5.90	4.93	3.77
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	9.35	14.54	1.04	0.00	3.12	2.08	1.04	5.19	3.12	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	6.52	8.46	0.18	3.17	0.88	3.35	1.06	2.29	1.23	1.94
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	3.74	4.37	0.94	1.25	1.71	2.81	2.03	1.09	1.87	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	3.65	1.22	0.54	0.81	0.54	2.43	0.81	0.27	1.08	1.08
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	2.12	0.35	0.00	0.35	0.35	0.71	0.35	0.35	1.06	0.71
Fibroblast - Gingival, donor7 (control)	11924-125H7	0.44	0.15	0.00	0.00	0.00	0.00	0.00	0.00	0.15	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	1.64	0.55	1.50	0.55	0.68	0.14	0.82	0.27	0.27	0.95
Fibroblast - Gingival, donor8 (control)	11926-125H9	9.87	9.32	5.92	2.19	2.74	1.86	2.08	2.41	0.66	1.65
Fibroblast - Gingival, donor9 (control)	11927-125I1	7.19	6.31	0.73	1.91	0.73	0.15	0.44	2.35	1.76	1.76
Fibroblast - Lung, donor1	11270-116H1	4.08	1.36	1.36	1.36	0.00	4.08	1.36	2.72	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	8.95	19.40	10.45	4.48	8.95	8.95	0.00	1.49	5.97	1.49
Fibroblast - Lung, donor3	11419-118F6	6.33	3.80	6.96	0.42	2.95	1.48	0.21	2.11	1.27	0.63
Fibroblast - Lymphatic, donor1	11506-119G3	0.00	3.33	0.83	0.83	2.50	0.83	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	2.80	4.20	1.40	1.40	1.40	2.80	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	0.00	1.40	0.56	0.00	0.84	1.12	0.28	0.00	0.00	0.28
Fibroblast - Mammary, donor1	11540-120B1	4.47	4.87	0.00	1.62	2.44	0.41	0.81	3.65	0.41	0.00
Fibroblast - Mammary, donor2	11620-122A9	0.00	3.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	0.00	5.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	11.83	12.80	5.63	3.88	5.24	6.98	1.36	3.10	3.49	2.91
Fibroblast - Periodontal Ligament, donor2	11319-117D5	11.98	18.51	4.10	1.97	5.16	6.52	0.91	6.52	4.40	3.64
Fibroblast - Periodontal Ligament, donor3	11395-118C9	15.61	13.16	3.06	4.90	4.59	7.34	3.06	4.59	4.28	3.06
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	6.87	5.72	0.76	1.53	0.38	1.53	1.53	2.67	2.29	1.14
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	6.75	8.64	0.00	2.16	0.81	1.08	1.35	1.89	1.08	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	7.77	9.05	0.46	2.67	0.81	1.16	0.81	3.02	2.55	1.74
Fibroblast - Pulmonary Artery, donor1	11250-116E8	9.40	10.28	3.65	3.21	4.64	7.41	2.43	2.87	2.21	0.77
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	2.24	5.89	0.61	0.61	1.42	2.64	0.61	1.83	0.61	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	1.34	4.01	0.00	0.67	2.00	0.00	0.67	1.34	0.00	1.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	2.37	6.33	1.19	1.19	2.37	0.40	0.00	1.58	1.98	1.98
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	9.72	14.49	9.33	1.39	6.95	0.99	0.00	2.58	0.40	0.60
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	8.17	9.24	2.31	1.42	1.78	0.53	0.71	2.84	1.95	1.42
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	9.07	19.91	4.53	5.52	3.55	2.76	1.58	3.74	3.55	1.18
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	11.43	14.74	15.34	2.11	9.63	2.11	3.61	5.42	0.90	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	11.33	10.36	5.18	3.24	3.13	0.86	0.76	2.37	2.37	2.59
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	17.21	36.19	5.82	2.53	10.38	8.86	2.02	3.29	1.52	0.51
Fibroblast - skin normal, donor1	11553-120C5	15.26	15.10	1.31	5.25	2.63	4.27	2.30	3.45	2.30	1.97
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	15.64	22.06	26.07	3.41	14.64	7.42	3.61	5.01	1.20	1.60
Fibroblast - skin normal, donor2	11561-120D4	12.06	12.86	10.25	2.91	6.63	2.71	1.71	2.61	1.11	1.41
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	15.41	24.48	9.37	2.72	9.37	3.93	2.12	3.63	0.30	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	12.43	16.57	3.07	4.72	3.15	3.98	1.82	4.97	3.23	2.07
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	7.69	8.89	2.56	1.37	2.91	0.85	0.34	3.42	1.88	2.56
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	8.87	13.79	3.28	1.97	3.61	2.30	0.33	5.58	0.33	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	6.07	4.79	0.75	1.60	2.13	0.85	0.64	0.75	0.64	0.64
Fibroblast - skin walker warburg, donor1	11554-120C6	5.74	6.58	1.35	1.69	0.84	3.04	0.67	1.35	0.51	1.01
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	12.23	8.78	1.73	2.67	2.82	5.18	2.04	0.94	1.10	1.41
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	0.00	0.00	22.16	0.00	22.16	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	27.02	4.36	12.20	5.23	4.36	3.49	0.87	0.00	2.61	2.61
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	30.68	35.71	7.97	13.18	7.97	8.49	14.22	7.63	5.89	2.25
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	32.79	36.69	9.37	12.23	10.93	16.66	8.85	9.89	6.77	2.34
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	31.17	23.51	10.73	10.48	11.50	10.99	8.69	5.88	8.43	3.58
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	16.84	12.25	2.30	8.42	0.77	6.89	11.48	3.83	2.30	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	18.50	11.49	3.19	6.38	3.19	9.57	7.02	5.10	2.55	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	44.22	23.11	5.42	12.27	3.99	6.85	9.13	11.13	3.99	2.85
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	23.72	3.58	1.65	4.14	1.10	0.28	1.10	3.31	1.93	0.55
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	23.75	22.15	5.48	5.25	2.51	3.88	2.28	5.48	1.14	0.91
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	30.51	21.60	2.97	5.55	2.77	5.15	7.13	10.50	2.77	1.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	16.92	3.97	2.38	3.44	1.59	0.26	2.91	1.85	2.38	0.53
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	29.03	24.46	6.52	6.20	5.22	5.54	3.26	6.52	0.98	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	38.03	24.32	3.98	6.19	4.86	4.86	11.50	11.94	3.98	2.65
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	40.56	20.77	5.51	7.49	2.83	3.82	7.07	9.89	6.64	3.96
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	24.26	14.90	3.45	3.57	2.59	4.06	4.80	3.94	4.68	3.57
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	34.12	13.43	2.15	6.72	4.57	2.95	8.86	7.25	4.57	3.49
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	19.20	23.91	4.34	3.72	3.47	2.85	5.58	4.21	3.59	2.73
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	28.24	36.13	4.71	5.68	5.12	6.09	5.26	8.44	5.26	3.88
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	21.14	29.89	6.51	9.35	8.54	6.10	7.32	6.91	4.27	2.64
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	14.83	12.09	4.34	3.65	2.51	3.19	4.79	3.42	1.60	2.05
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	19.31	21.67	6.35	3.61	4.73	5.48	5.36	5.11	1.99	1.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	21.20	20.98	6.56	3.93	6.78	4.59	4.37	7.21	2.40	1.31
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	17.73	11.82	4.73	4.43	3.25	4.43	5.32	4.73	2.95	1.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	22.89	22.10	7.31	4.13	3.81	4.13	5.09	3.34	1.59	2.07
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	24.13	22.57	5.59	5.59	5.14	5.59	3.57	7.37	2.46	1.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	12.50	6.45	2.62	2.22	2.62	1.81	3.43	2.02	0.81	1.41
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	16.79	10.86	6.62	2.21	3.39	3.73	3.56	2.54	2.37	1.87
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	22.43	28.46	11.44	7.01	10.64	8.51	9.22	5.85	3.01	1.60
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	18.21	8.53	5.51	4.06	2.91	3.54	3.33	2.91	1.46	1.14
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	16.74	8.88	4.61	2.39	3.24	3.93	3.93	2.56	2.90	1.02
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	15.16	6.86	3.87	2.21	2.10	1.33	1.99	1.11	2.21	0.55
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	15.22	15.64	6.99	3.83	6.16	5.07	4.99	3.83	2.33	1.58
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	17.36	13.48	7.76	3.47	4.49	3.27	3.47	2.86	2.04	1.43
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	12.58	7.01	3.30	2.06	2.89	1.03	2.68	2.68	2.06	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	15.91	9.57	4.27	3.11	1.61	1.84	2.19	2.54	1.50	1.04
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	13.17	11.17	2.67	1.33	3.67	2.50	2.84	2.67	1.33	1.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	10.80	6.39	2.42	1.10	0.88	0.44	1.32	2.42	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	14.02	8.86	2.71	1.23	1.23	1.48	2.83	2.71	2.21	0.98
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	19.61	9.08	5.02	2.43	3.24	1.46	4.21	2.59	1.13	0.97
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	12.83	7.06	3.85	1.60	0.96	1.92	1.60	2.57	1.28	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	10.14	5.97	1.33	1.80	1.04	1.23	1.33	1.04	0.85	1.04
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	5.54	6.49	1.42	0.63	0.79	1.42	1.42	1.27	0.95	0.47
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	6.69	6.08	1.82	0.91	0.91	0.91	0.61	2.13	1.22	1.22
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	10.77	6.90	1.78	2.40	0.73	0.84	1.78	1.46	1.36	0.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	7.03	4.17	1.98	1.54	1.76	1.10	0.88	1.76	1.98	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	9.26	4.21	2.52	1.68	0.84	0.28	1.96	1.40	1.40	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	7.50	4.35	1.20	0.65	0.46	0.93	1.85	1.11	0.65	0.46
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	2.67	3.48	2.14	0.80	1.87	1.34	0.80	1.34	0.00	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	6.73	4.74	2.14	1.38	1.22	0.46	0.61	1.22	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	4.53	4.79	0.78	0.65	0.52	1.04	1.68	0.78	0.91	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	3.80	1.90	1.36	0.54	0.27	0.27	1.08	1.36	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	6.64	7.93	1.29	1.11	1.11	1.11	3.87	1.11	2.03	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	8.33	5.26	2.19	1.97	1.10	0.88	1.32	1.97	1.75	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	2.98	4.96	0.99	1.98	0.99	1.98	0.99	2.98	2.98	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	7.52	7.65	3.17	2.64	2.64	2.11	1.98	2.24	1.98	1.19
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	6.66	6.86	2.62	1.61	1.41	1.82	0.81	4.44	1.61	1.21
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	14.49	12.20	7.12	5.34	2.03	1.78	4.07	3.81	3.81	2.80
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	60.91	35.43	5.18	18.51	6.17	4.38	8.96	11.15	8.96	6.57
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	36.05	30.82	5.55	8.63	3.54	3.70	5.55	9.40	7.40	3.85
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	64.24	34.98	6.34	14.12	4.09	3.89	9.82	14.73	9.82	5.11
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	29.42	11.27	2.19	6.88	2.82	3.44	12.83	3.76	5.01	2.50
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	20.91	12.43	1.13	6.78	2.26	1.70	6.78	3.67	3.67	1.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	48.43	22.14	1.84	9.22	4.61	4.61	11.07	5.07	5.07	2.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	22.27	22.27	0.00	2.47	2.47	9.90	14.85	2.47	4.95	4.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	28.24	15.86	3.87	8.90	4.64	7.35	10.06	4.64	4.25	2.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	27.28	14.44	6.42	3.21	1.60	8.02	16.04	4.81	4.81	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	34.78	19.13	5.22	6.96	3.48	0.00	10.43	6.96	3.48	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	23.43	12.37	2.60	5.53	4.88	4.23	5.86	2.60	1.95	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	21.83	17.71	7.82	3.71	4.12	4.94	9.06	2.88	2.47	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	26.66	10.00	3.33	10.00	3.33	3.33	6.66	3.33	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	15.94	14.54	2.24	4.75	4.19	4.75	7.27	3.36	2.52	1.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	20.59	14.38	4.25	4.58	3.92	5.23	4.58	3.92	2.94	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	24.33	15.94	5.03	4.19	5.03	4.19	4.19	1.68	1.68	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	21.95	8.27	4.13	4.13	6.36	2.23	4.45	4.13	1.91	1.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	17.66	12.23	4.76	3.40	1.36	4.42	2.72	3.40	1.70	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	31.32	10.44	0.00	2.09	4.18	4.18	10.44	2.09	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	20.62	9.16	1.15	4.58	3.44	2.86	5.73	2.86	0.57	2.29
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	10.36	8.29	2.07	1.78	1.48	1.78	3.55	1.78	0.59	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	18.64	6.78	6.78	1.69	3.39	8.47	0.00	5.08	3.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	16.15	10.77	9.11	4.56	4.14	4.97	9.53	2.07	0.41	2.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	15.65	8.98	5.98	2.76	4.14	4.60	11.28	3.68	2.99	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	15.81	15.81	0.00	5.27	0.00	5.27	0.00	0.00	5.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	12.30	8.84	4.61	2.31	2.31	5.00	5.00	3.08	1.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	10.11	8.80	4.24	1.96	3.59	3.91	8.80	3.26	1.63	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	10.03	16.05	2.01	2.68	4.01	4.01	3.34	2.01	2.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	13.87	9.63	5.01	2.70	4.24	1.16	6.16	7.32	1.54	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	23.62	30.81	13.01	4.79	9.24	7.53	9.24	9.59	5.14	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	12.42	17.39	4.97	2.48	2.48	2.48	4.97	4.97	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	14.63	13.68	4.72	4.72	5.19	1.89	2.83	3.30	2.83	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	16.29	10.86	1.81	3.02	3.02	1.81	3.62	4.22	4.83	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	13.23	16.79	6.10	3.56	2.03	2.54	6.61	3.56	0.51	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	18.75	16.35	3.19	3.19	3.59	3.59	7.18	3.19	3.19	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	17.27	15.79	3.95	2.47	4.44	2.96	8.39	4.93	1.97	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	15.35	34.23	2.36	4.72	1.18	2.36	11.80	5.90	3.54	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	14.59	11.09	4.08	2.92	1.17	2.33	7.58	2.33	1.75	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	11.41	14.04	2.19	4.39	3.51	3.07	6.14	3.07	1.76	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	15.26	13.56	5.09	2.54	6.78	3.39	7.63	6.78	2.54	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	10.74	8.95	2.98	3.58	0.60	1.19	5.37	2.98	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	10.19	7.28	4.37	2.91	0.97	1.94	3.88	2.91	1.46	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	0.00	1.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	1.25	1.66	0.00	0.00	0.00	0.00	0.42	0.00	1.25	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	1.27	1.27	0.63	0.00	0.32	0.00	0.32	0.32	0.63	0.63
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	2.09	0.84	0.00	0.42	0.00	0.00	0.42	0.42	0.00	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	35.86	17.64	25.30	9.75	14.62	9.40	11.72	4.64	5.34	3.25
Hep-2 cells mock treated, biol_rep2	11899-125E9	36.97	22.45	21.94	9.45	15.19	8.10	8.61	3.38	5.91	5.40
Hep-2 cells mock treated, biol_rep3	11900-125F1	35.04	14.11	18.66	10.69	12.51	6.37	7.96	2.28	6.60	3.87
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	36.29	20.22	24.70	9.40	14.76	9.73	10.17	4.37	5.68	3.61
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	40.62	21.49	21.71	10.32	12.46	8.38	9.67	3.01	4.30	3.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	35.09	15.72	18.94	10.55	10.98	8.61	8.61	2.37	7.53	3.66
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	25.65	14.82	18.43	7.97	9.71	6.85	9.34	3.99	3.61	2.99
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	30.19	14.58	19.39	8.41	11.49	8.06	8.58	2.06	6.52	3.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	28.19	11.85	14.42	9.61	13.46	4.16	8.33	2.56	5.77	2.24
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	1.68	2.80	1.12	0.00	1.12	0.56	0.00	0.56	1.12	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	1.30	3.46	0.43	0.00	0.00	0.43	0.00	0.43	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	2.64	5.29	18.51	0.00	2.64	5.29	0.00	0.00	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	1.41	1.76	1.41	0.35	0.35	0.35	0.00	0.71	0.00	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	0.73	0.00	0.00	0.00	0.73	0.73	0.00	1.45	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	6.29	6.12	15.74	2.97	3.32	2.80	0.87	1.05	0.52	0.35
Hepatocyte, donor1	11523-119I2	9.68	1.21	0.00	1.21	0.00	0.00	0.00	0.00	2.42	0.00
Hepatocyte, donor2	11603-120I1	25.86	6.46	0.00	6.46	2.15	0.00	2.15	0.00	2.15	1.08
Hepatocyte, donor3	11684-122I1	6.75	3.68	1.23	2.45	1.23	3.07	1.23	2.45	2.45	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	46.34	7.83	1.96	12.40	1.31	1.96	5.22	3.92	6.53	5.87
Intestinal epithelial cells (polarized), donor1	11246-116E4	53.31	22.55	14.51	14.16	7.87	7.69	7.34	6.47	3.67	2.45
Iris Pigment Epithelial Cells, donor1	11530-119I9	12.07	16.19	2.61	2.06	3.70	5.49	1.78	5.21	2.61	1.37
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	0.00	3.18	0.00	0.00	6.37	3.18	0.00	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	0.00	6.68	0.00	0.00	6.68	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	4.15	1.38	1.38	0.00	1.38	0.00	0.00	1.38	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	2.50	5.01	7.51	2.50	2.50	2.50	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	11.87	0.00	11.87	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	2.56	7.69	0.00	0.00	0.00	0.00	0.00	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	4.57	13.71	0.00	0.00	4.57	4.57	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	6.50	4.87	1.62	0.00	1.62	1.62	0.00	1.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	5.00	6.67	0.00	0.00	1.67	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	3.63	10.89	0.00	0.00	3.63	0.00	0.00	3.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	3.97	2.65	1.32	0.00	2.65	2.65	0.00	1.32	0.00	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	1.11	1.11	0.00	1.11	1.11	2.22	2.22	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	5.24	0.00	0.00	5.24	15.71	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	3.78	4.41	3.78	1.26	1.89	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	1.55	6.19	3.09	0.00	3.09	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	3.23	5.17	1.29	0.00	2.58	0.65	1.29	1.94	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	3.22	11.27	0.00	0.00	0.00	0.00	1.61	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	35.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	0.81	7.33	3.26	1.63	2.44	0.81	0.00	0.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	0.84	4.20	0.00	1.26	0.42	0.84	0.84	0.42	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	3.21	9.64	1.61	0.80	6.43	2.41	0.80	0.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	4.62	2.77	1.85	0.00	3.69	1.85	0.00	0.00	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	15.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	4.25	2.36	2.36	1.42	2.36	1.42	0.94	1.42	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	0.91	3.63	1.81	0.00	0.91	1.81	0.00	0.91	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	14.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	0.00	4.30	0.00	0.00	1.08	1.08	0.00	2.15	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	0.00	1.27	0.00	1.27	1.27	1.27	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00	0.00	16.43	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	2.55	6.38	2.55	0.00	0.64	2.55	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	1.82	5.47	0.00	1.82	1.82	0.00	0.00	1.82	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	15.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	0.71	5.71	0.71	0.00	1.43	2.86	0.00	1.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	9.95	3.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	20.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	0.93	3.70	2.16	1.54	0.31	1.85	0.31	0.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	1.76	3.51	0.00	1.76	0.00	1.76	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	9.43	0.00	0.00	0.00	0.00	3.14	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	4.87	5.56	0.00	0.00	0.00	2.09	0.00	0.70	0.70	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	4.43	2.21	2.21	4.43	2.21	4.43	0.00	0.00	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	3.24	6.48	0.00	3.24	3.24	3.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	3.49	13.95	5.23	0.87	0.00	3.49	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	4.50	6.75	6.75	2.25	2.25	6.75	0.00	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	3.48	6.97	0.00	0.00	6.97	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	3.20	10.67	3.20	1.07	5.33	3.20	0.00	1.07	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	5.54	9.70	2.77	1.39	1.39	4.16	2.77	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	0.00	0.00	2.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	3.68	6.44	2.76	1.84	0.92	3.68	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	6.05	15.13	0.00	0.00	6.05	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	12.42	6.21	0.00	6.21	0.00	0.00	6.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	2.11	13.75	0.00	0.00	4.23	5.29	0.00	1.06	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	19.83	19.18	5.63	7.59	6.85	8.32	5.14	4.65	5.55	3.67
Keratinocyte - epidermal, donor2	11349-117G8	9.37	18.74	1.17	4.10	7.61	2.93	1.17	1.17	3.51	2.34
Keratinocyte - epidermal, donor3	11421-118F8	27.36	28.68	8.71	6.44	8.33	10.03	4.26	4.54	8.05	3.31
Keratinocyte - oral, donor1	11251-116E9	27.36	21.68	6.24	7.83	6.36	7.95	3.06	7.49	10.78	6.81
Keratocytes, donor1	11527-119I6	9.63	32.66	13.41	2.06	8.60	3.44	0.34	1.38	2.41	1.03
Keratocytes, donor2	11607-120I5	2.34	3.52	2.34	0.00	0.00	3.52	0.00	0.00	1.17	0.00
Keratocytes, donor3	11688-122I5	24.30	33.00	38.93	9.68	8.30	3.95	1.78	5.93	6.92	1.19
Krukenberg tumor cell line:HSKTC	10687-109F3	30.77	19.78	2.20	8.79	2.20	0.00	2.20	6.59	4.40	6.59
Lens Epithelial Cells, donor1	11529-119I8	5.39	10.79	3.24	1.08	4.31	1.08	0.00	0.00	3.24	1.08
Lens Epithelial Cells, donor2	11609-120I7	9.80	3.81	0.92	1.38	1.04	1.38	0.35	0.81	1.38	0.92
Lens Epithelial Cells, donor3	11690-122I7	16.25	24.02	7.57	3.73	4.94	8.17	2.83	7.87	2.22	2.42
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	11.50	17.55	8.54	5.81	5.34	4.39	3.20	2.85	4.74	0.71
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	6.14	7.54	9.49	4.19	2.79	1.40	2.23	1.67	1.12	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	20.94	25.03	12.28	9.76	8.97	7.24	6.61	4.09	3.62	1.89
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	8.60	9.68	6.99	2.15	3.23	2.15	3.23	1.08	1.08	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	5.04	7.88	9.45	4.10	1.89	0.32	1.58	1.58	1.58	0.95
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	7.12	8.63	7.01	3.56	2.48	3.34	1.40	1.29	2.16	0.97
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	9.85	12.72	11.08	6.57	3.69	1.64	3.28	2.46	1.64	1.64
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	3.79	4.55	4.80	1.52	0.76	0.51	1.01	0.51	0.51	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	9.71	12.10	7.04	3.24	4.64	2.67	2.96	2.25	2.11	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	10.68	16.22	10.28	5.54	4.75	3.96	3.96	2.77	1.58	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	8.92	7.95	17.45	4.65	1.94	0.97	3.88	1.36	1.94	1.16
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	6.30	4.44	2.78	2.78	0.93	0.56	1.11	1.11	1.30	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	11.50	14.98	9.41	3.14	3.83	1.74	3.83	2.44	1.39	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	6.44	9.06	11.45	4.53	3.34	0.95	1.67	1.19	1.43	0.72
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	6.04	10.44	6.87	3.43	2.61	2.75	2.75	1.65	1.37	1.65
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	10.16	16.94	5.85	4.31	4.62	4.62	5.24	2.77	1.23	1.23
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	5.61	3.43	6.86	1.87	2.49	0.00	0.94	0.31	1.87	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	8.23	12.44	7.50	2.56	2.01	2.93	3.66	2.01	1.46	1.28
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	8.23	13.16	6.91	4.61	2.63	1.32	2.96	0.99	2.30	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	1.46	4.10	5.86	2.93	1.46	0.29	1.17	0.88	0.00	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	5.23	8.71	6.22	2.99	2.74	2.24	1.49	1.00	0.25	0.50
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	13.09	15.52	10.18	5.33	2.91	3.88	4.36	1.45	1.45	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	9.96	9.69	15.35	2.69	2.69	1.08	2.96	1.89	1.35	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	8.33	15.14	10.14	4.24	5.75	3.94	4.54	1.97	2.27	1.36
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	8.29	10.89	10.89	1.56	4.67	1.04	1.56	0.00	1.04	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	11.73	11.31	22.40	6.28	4.61	1.26	6.28	2.09	3.56	1.88
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	12.03	13.08	7.82	4.06	3.31	2.56	3.01	0.90	2.11	1.05
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	9.63	15.82	7.57	5.50	3.44	1.38	2.75	0.69	2.06	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	8.47	8.65	14.30	2.26	3.57	0.38	3.01	1.88	1.51	0.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	6.89	8.80	4.35	2.76	1.70	2.33	1.59	0.85	1.27	0.42
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	15.02	15.99	8.72	8.72	3.39	5.81	3.88	0.48	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	7.94	7.94	10.92	2.98	3.64	1.32	0.99	0.99	1.65	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	6.69	10.16	5.08	2.35	2.73	1.73	2.35	1.12	0.99	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	11.85	30.73	22.21	10.74	5.92	5.92	8.89	3.70	4.07	1.48
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	7.66	6.92	12.60	3.95	3.95	1.98	1.98	1.98	2.72	0.99
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	5.64	9.21	5.64	3.16	2.06	2.75	2.06	0.96	1.24	0.55
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	10.94	16.08	10.94	3.86	3.54	2.25	2.89	1.61	2.89	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	10.96	16.43	18.56	6.09	5.48	0.61	2.43	1.83	2.74	1.22
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	12.32	17.36	14.98	6.44	4.48	4.06	4.34	2.66	2.10	0.98
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	12.09	12.44	11.02	4.62	4.98	4.62	3.56	2.49	2.84	1.78
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	2.91	7.27	8.24	1.94	1.94	1.94	1.94	0.97	1.94	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	4.51	7.31	4.36	0.93	1.56	1.24	0.93	0.93	0.47	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	5.73	11.46	9.31	6.45	2.51	3.94	5.01	2.51	2.51	1.07
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	5.23	12.74	14.05	2.29	2.94	1.31	1.96	1.63	1.31	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	3.30	7.30	3.53	1.88	2.12	1.41	0.47	0.24	1.18	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	12.99	23.76	15.47	5.45	7.18	4.46	3.09	2.85	3.84	0.99
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	4.61	8.45	8.96	2.31	1.79	0.26	1.02	1.02	2.05	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	10.74	12.23	6.86	2.39	3.58	1.49	2.09	1.49	3.28	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	18.13	13.60	15.86	15.86	9.06	6.80	45.32	2.27	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	28.38	12.27	10.74	7.67	5.37	2.30	13.81	3.07	6.14	3.84
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	27.46	10.39	13.36	3.71	5.20	5.20	11.88	1.48	2.23	2.97
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	26.66	9.31	11.42	5.50	8.89	6.35	17.77	2.12	7.19	3.39
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	30.95	8.44	11.25	4.92	1.41	2.11	13.36	2.81	3.52	2.81
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	24.28	6.54	6.54	7.47	3.74	1.87	15.88	1.87	2.80	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	19.58	5.15	13.91	5.67	4.64	3.61	16.49	1.55	3.61	2.58
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	24.98	4.76	13.08	1.19	2.38	4.76	14.27	0.00	2.38	3.57
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	23.30	7.24	15.61	5.65	4.52	4.75	21.49	1.36	4.30	1.36
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	27.05	9.31	22.68	9.31	9.02	5.82	28.79	0.87	4.94	3.49
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	38.26	14.86	21.61	6.75	7.20	2.25	21.61	1.35	7.20	1.35
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	34.01	11.92	16.94	9.48	7.18	5.83	26.96	2.44	5.01	2.30
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	21.05	8.22	16.43	9.76	5.65	6.68	21.57	1.03	6.68	1.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	37.40	8.47	15.17	6.70	5.65	5.65	20.47	2.12	6.70	1.76
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	34.65	10.66	12.66	8.66	4.66	4.66	13.33	0.67	4.66	2.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	23.94	12.73	16.81	8.15	6.62	3.06	21.39	1.53	5.09	3.06
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	46.16	13.07	18.94	8.27	7.20	6.67	26.68	1.87	8.27	3.74
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	50.07	15.87	24.56	9.07	6.99	6.05	30.04	1.89	4.35	3.02
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	27.00	7.98	17.18	12.27	5.52	4.29	22.70	1.84	1.23	3.68
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	47.29	13.05	17.94	4.89	4.89	2.45	20.39	0.00	7.34	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	42.07	14.99	22.91	6.87	6.87	5.83	25.61	3.12	9.16	3.54
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	34.19	18.50	26.34	12.33	10.09	5.61	29.71	1.68	7.29	3.92
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	39.15	11.33	15.46	3.09	6.18	3.09	19.58	2.06	6.18	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	36.00	11.32	17.71	6.39	8.42	5.23	27.87	1.74	4.35	3.19
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	29.89	17.34	20.33	10.46	7.47	8.67	23.02	2.09	5.98	1.20
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	45.92	12.17	19.92	6.64	9.41	4.43	23.79	1.66	8.85	3.87
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	31.81	11.31	15.55	5.30	9.54	3.18	22.27	3.18	5.66	2.83
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	25.81	14.38	19.18	5.90	7.01	6.27	23.23	1.84	2.21	2.95
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	26.48	12.66	6.91	5.76	9.21	2.30	10.36	1.15	5.76	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	33.00	14.97	13.05	6.52	6.52	5.37	19.57	1.15	7.68	2.30
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	27.17	11.32	12.45	8.49	5.10	5.10	20.38	1.13	2.26	1.70
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	24.61	13.95	12.31	6.56	4.92	4.10	13.95	1.64	5.74	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	26.21	16.27	16.27	3.16	5.87	4.07	16.27	2.26	3.62	2.71
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	20.11	8.62	10.05	7.18	10.77	3.59	17.95	2.15	7.90	2.87
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	33.61	7.47	17.18	8.96	4.48	4.48	14.19	2.99	2.99	2.24
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	29.36	7.06	9.66	5.57	5.20	5.57	17.46	2.23	5.20	2.97
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	28.00	11.20	13.78	6.46	3.88	6.03	11.20	2.58	2.58	2.58
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	26.55	6.85	13.70	5.99	5.14	4.28	14.56	3.43	4.28	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	21.99	9.00	14.66	5.66	8.33	4.66	24.32	1.33	5.33	2.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	22.32	9.05	15.69	9.05	6.64	4.22	14.48	0.60	7.84	2.41
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	30.57	8.53	5.69	3.55	3.55	3.55	8.53	0.00	4.27	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	29.22	7.91	11.34	8.25	4.47	1.03	17.53	0.34	3.78	1.03
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	16.64	11.27	13.42	6.44	6.44	5.37	18.25	0.54	5.90	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	19.53	6.06	9.43	4.04	4.04	4.04	14.14	1.35	10.10	2.02
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	20.00	11.48	15.93	5.19	6.30	5.19	20.00	1.48	4.82	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	32.56	4.65	6.98	10.47	8.14	2.33	19.77	2.33	6.98	5.81
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	26.44	6.35	3.17	4.23	7.40	3.17	5.29	1.06	4.23	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	25.61	8.00	14.01	7.60	2.80	3.20	14.81	1.20	5.20	3.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	29.80	9.45	10.90	5.09	8.00	7.27	21.81	1.45	6.54	2.91
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	39.09	11.50	16.86	6.13	3.83	4.60	21.46	0.77	5.37	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	25.16	10.36	25.65	3.95	4.93	3.45	34.04	2.96	3.95	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	13.17	14.11	13.17	13.17	5.65	3.76	16.00	0.94	4.70	4.70
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	34.69	11.06	15.08	7.04	6.03	4.02	20.62	2.51	4.53	2.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	36.05	11.27	18.02	8.11	7.21	3.60	14.87	0.00	7.21	1.35
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	22.37	17.21	15.49	6.88	5.16	3.44	13.77	0.00	1.72	3.44
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	32.51	11.58	16.48	6.23	4.90	4.45	20.93	2.67	5.34	1.34
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	28.94	12.12	16.42	7.43	2.74	2.35	19.16	2.35	6.65	2.74
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	16.49	11.22	11.88	8.58	3.96	4.62	18.47	1.98	2.64	1.32
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	35.81	10.38	10.90	7.26	4.67	2.08	14.53	1.04	8.30	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	31.07	10.06	12.25	6.56	7.00	3.94	19.25	1.75	3.94	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	23.48	13.98	16.21	10.06	7.27	8.39	21.80	2.24	5.59	2.24
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	33.56	9.27	13.69	6.18	5.30	8.39	15.02	1.77	7.07	1.77
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	32.40	14.66	16.59	6.17	6.94	3.47	20.44	2.31	5.79	2.70
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	34.43	11.14	16.71	7.09	8.61	5.06	17.72	4.05	7.09	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	32.20	9.13	14.42	8.65	5.77	3.84	15.86	1.44	3.36	1.44
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	29.02	9.54	17.49	7.16	4.77	3.98	19.88	1.19	7.55	3.58
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	24.91	10.33	14.58	4.25	7.90	8.51	20.05	1.22	2.43	1.82
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	19.37	9.68	14.53	8.99	4.84	0.69	10.38	0.00	4.15	3.46
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	26.22	14.44	18.24	5.70	7.60	6.84	23.94	2.66	3.42	2.28
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	26.34	16.01	21.17	8.26	6.71	6.20	23.24	3.61	3.61	1.55
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	24.79	8.47	12.09	3.63	4.84	5.44	19.35	1.21	5.44	2.42
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	37.71	8.24	17.11	5.70	5.70	7.29	22.82	1.58	5.70	2.54
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	26.65	11.73	10.66	10.66	6.93	4.80	17.06	2.13	10.66	3.73
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	29.31	9.19	14.37	2.87	9.19	6.32	13.79	0.00	2.87	4.02
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	29.31	11.83	16.97	7.20	6.17	6.17	13.37	2.06	8.74	2.06
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	20.51	15.56	19.81	8.49	9.20	4.24	14.15	2.12	7.78	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	27.81	12.48	15.32	3.40	7.94	2.27	10.78	1.13	3.97	5.11
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	27.87	9.15	16.64	7.07	4.99	4.16	14.14	1.25	5.41	3.33
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	27.41	12.53	18.01	6.26	3.92	5.48	20.36	0.00	2.35	2.35
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	22.13	8.77	17.12	5.85	5.43	5.01	13.36	1.67	5.85	2.09
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	29.27	11.15	13.94	7.43	4.65	3.72	21.84	0.93	5.11	2.32
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	23.42	10.70	11.37	5.35	6.02	4.01	11.37	2.68	4.68	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	26.73	8.02	13.90	4.81	5.35	3.74	12.83	1.07	2.67	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	26.67	12.53	15.36	5.25	5.66	4.45	16.16	1.62	3.64	0.81
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	14.68	8.26	15.60	8.26	3.67	7.34	10.10	1.84	2.75	2.75
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	26.67	8.89	9.78	3.56	5.33	0.89	10.67	0.00	2.67	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	17.67	11.97	9.12	1.14	3.42	5.13	10.83	1.71	3.99	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	9.20	6.14	13.80	7.67	1.53	5.37	11.50	3.07	3.83	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	26.81	11.49	9.85	4.92	7.11	3.83	9.30	1.09	1.64	2.19
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	27.17	10.25	8.91	4.45	5.35	5.79	9.35	1.78	3.12	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	20.02	9.36	14.30	7.80	8.58	3.90	16.12	2.08	4.68	3.38
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	21.88	5.97	5.97	5.30	5.97	4.64	9.28	0.00	2.65	2.65
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	14.55	8.31	6.24	2.08	10.39	2.08	6.24	2.08	6.24	2.08
Macrophage - monocyte derived, donor1	11232-116C8	0.23	0.00	0.00	0.23	0.00	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	0.92	0.37	0.00	0.00	0.37	0.00	0.18	0.00	0.00	0.18
Macrophage - monocyte derived, donor3	11389-118C3	1.05	0.00	0.00	0.52	0.13	0.00	0.39	0.00	0.13	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	21.77	26.02	3.19	12.74	5.84	7.43	7.97	5.31	5.31	5.31
Mallassez-derived cells, donor2	11929-125I3	34.23	25.04	10.77	7.29	11.73	5.55	7.76	5.55	3.96	2.38
Mallassez-derived cells, donor3	11930-125I4	25.71	30.44	12.23	7.64	11.54	9.17	6.25	5.00	4.31	3.34
Mammary Epithelial Cell, donor1	11273-116H4	44.54	53.21	36.77	12.06	18.73	24.41	9.07	8.27	8.37	2.19
Mammary Epithelial Cell, donor2	11350-117G9	41.12	40.25	17.66	10.71	19.40	14.19	6.95	4.34	6.37	2.61
Mammary Epithelial Cell, donor3	11422-118F9	8.48	7.73	3.74	2.74	4.49	3.99	1.25	2.24	3.24	1.50
Mast cell - stimulated, donor1	11487-119E2	0.00	0.00	0.68	0.00	0.00	0.68	0.00	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	0.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mast cell, donor2	11565-120D8	2.97	1.78	2.08	0.59	2.38	0.59	0.89	1.19	0.89	0.89
Mast cell, donor3	11566-120D9	0.90	0.23	0.23	0.23	0.00	0.23	0.00	0.00	0.00	0.00
Mast cell, donor4	11567-120E1	0.71	0.00	0.00	0.18	0.35	0.00	0.00	0.00	0.18	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	0.44	0.22	0.44	0.00	0.11	0.00	0.00	0.11	0.00	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	0.58	2.33	0.58	0.00	1.17	0.58	0.00	0.58	0.00	0.58
Mast cell, expanded, donor5	11939-126A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mast cell, expanded, donor8	11941-126A6	0.17	0.17	0.17	0.17	0.00	0.00	0.17	0.00	0.00	0.17
Melanocyte - dark, donor1	11502-119F8	19.50	20.99	16.91	5.77	9.05	5.27	5.17	3.78	3.38	1.69
Melanocyte - dark, donor2	11582-120F7	2.08	2.77	2.42	1.04	0.69	0.69	0.00	1.04	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	0.07	0.43	0.00	0.14	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte - light, donor1	11274-116H5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte - light, donor2	11351-117H1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	4.34	1.73	0.00	0.87	0.00	0.00	0.87	0.00	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	0.10	0.31	0.00	0.00	0.21	0.00	0.00	0.10	0.00	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Meningeal Cells, donor1	11493-119E8	7.32	17.49	5.09	2.11	6.45	4.22	1.36	3.10	0.74	0.62
Meningeal Cells, donor2	11573-120E7	5.72	10.56	5.28	2.20	2.64	1.76	0.00	4.84	0.88	0.00
Meningeal Cells, donor3	11654-122E7	9.45	15.65	7.17	3.34	6.52	6.93	2.53	4.08	1.55	1.39
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	4.85	2.28	2.85	0.57	1.14	1.71	0.57	2.28	1.14	0.86
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	13.28	24.76	8.25	5.43	5.94	5.74	4.43	5.13	2.21	2.11
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	1.31	0.00	0.00	0.00	0.00	2.63	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	0.00	0.00	1.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	1.44	2.15	2.87	0.00	0.00	1.44	0.00	0.72	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	20.12	21.60	4.66	6.14	6.35	6.14	5.08	5.08	2.33	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	14.07	14.58	5.03	3.52	4.02	4.52	5.03	2.01	2.01	2.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	1.10	1.54	0.44	0.44	0.00	1.32	0.44	0.88	0.44	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	3.65	2.19	2.19	0.00	0.73	2.19	0.73	1.46	0.73	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	1.64	2.46	0.61	0.20	0.20	1.02	0.00	1.23	0.41	0.61
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	3.46	2.22	0.28	0.69	0.14	0.83	0.00	1.39	1.66	0.97
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	1.86	2.60	0.37	1.12	0.74	0.74	0.37	0.37	0.37	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	8.95	18.29	6.71	3.42	4.34	5.79	0.92	6.45	3.82	1.05
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	1.19	2.08	1.19	0.59	0.00	0.00	0.00	3.26	1.19	0.89
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	4.67	4.67	2.34	0.00	0.00	0.00	0.00	0.00	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	1.28	5.12	3.20	1.28	2.56	0.64	0.00	0.00	2.56	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	0.71	2.13	2.48	0.71	1.42	0.71	0.35	0.71	1.42	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	7.82	9.38	4.07	1.25	3.13	5.94	0.31	2.19	2.81	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	6.53	8.71	3.63	0.73	2.90	2.90	0.00	1.45	0.73	1.45
Mesothelial Cells, donor1	11247-116E5	5.30	9.55	1.59	1.33	2.12	2.92	1.59	2.12	0.53	1.06
Mesothelial Cells, donor2	12156-128G5	4.50	9.01	4.50	1.50	2.00	2.00	1.00	2.00	1.00	1.00
Mesothelial Cells, donor3	11402-118D7	4.12	6.50	1.95	1.23	1.45	1.45	0.72	2.53	1.23	1.59
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	0.00	1.35	0.00	0.00	0.00	0.00	1.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	1.48	1.48	0.25	0.74	0.00	0.00	0.49	0.49	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	3.53	2.06	0.88	1.47	0.59	0.29	1.77	0.59	0.88	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	1.86	0.31	0.00	0.00	0.00	0.00	0.00	0.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	3.53	1.66	1.24	0.21	0.83	1.04	1.04	0.41	0.00	0.41
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	1.25	1.00	0.00	0.00	0.25	0.00	0.00	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	2.79	3.72	0.47	0.93	0.00	0.47	1.40	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	1.22	0.20	0.20	0.41	0.00	0.41	0.41	0.20	0.20	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	2.77	1.58	0.00	0.40	0.40	0.40	0.40	0.40	0.79	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	0.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	2.28	1.52	0.00	0.38	0.76	0.00	1.14	0.38	0.76	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	0.00	0.00	0.00	0.00	1.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	1.70	0.42	0.00	0.00	0.00	0.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	4.60	0.00	0.00	1.84	0.00	0.92	0.00	1.84	0.00	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	0.30	0.30	0.89	0.30	0.30	0.60	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	0.00	3.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	33.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	0.25	0.25	0.00	0.25	0.00	0.00	0.00	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	2.85	2.14	0.00	1.19	0.48	0.00	0.71	0.71	0.95	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	0.00	0.00	0.00	0.00	0.00	0.55	0.00	0.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	1.15	0.00	0.00	0.23	0.00	0.23	0.00	0.23	0.00	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	2.73	1.05	0.42	0.21	0.63	0.63	0.84	0.00	0.42	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	1.02	0.20	0.00	0.20	0.00	0.20	0.20	0.00	0.00	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	0.64	0.43	0.00	0.64	0.21	0.00	0.00	0.43	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	1.78	1.33	0.00	0.89	0.67	0.00	0.44	0.67	0.44	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	0.66	0.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	1.52	0.00	0.51	1.01	0.00	0.00	0.51	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	1.09	1.09	0.00	0.27	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	2.06	0.59	0.29	0.88	0.88	0.00	0.29	0.29	0.29	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	0.48	0.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	0.80	0.80	0.00	0.80	0.00	0.40	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	0.50	0.00	0.00	0.00	0.50	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	26.95	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	0.00	0.88	0.44	0.00	0.00	0.00	0.00	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	0.74	0.25	0.00	0.00	0.00	0.00	0.50	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	0.00	0.70	0.00	0.70	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	0.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	0.00	0.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	0.00	0.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	0.86	0.00	0.00	0.00	0.00	0.00	0.00	0.43	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	0.00	0.00	0.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	0.90	1.80	0.00	0.00	0.00	0.30	0.90	0.30	0.00	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	0.00	0.28	0.00	0.14	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	0.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	0.00	0.22	0.00	0.22	0.22	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	0.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	1.47	0.00	0.00	0.25	0.00	0.00	0.25	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	0.29	0.00	0.00	0.00	0.00	0.00	0.00	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	0.58	0.00	0.00	0.00	0.00	0.00	0.00	0.29	0.00	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	0.41	0.41	0.00	0.41	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	1.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	0.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	0.00	0.93	0.00	0.93	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	0.00	0.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	0.53	0.53	0.00	0.80	0.00	0.00	0.27	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	0.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	0.42	0.00	0.42	0.00	0.00	0.42	0.00	0.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	0.00	5.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	13.05	3.26	0.00	3.26	0.00	6.52	3.26	3.26	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	4.75	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	20.68	22.41	12.28	6.25	7.11	7.32	5.39	7.54	3.23	3.66
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	17.25	21.95	6.79	6.27	4.70	6.79	4.18	6.27	4.18	3.14
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	4.00	6.01	0.00	0.67	0.67	0.67	2.67	1.33	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	2.92	2.92	1.25	0.42	0.83	0.83	1.67	1.25	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	10.27	3.42	2.09	1.52	1.71	1.33	1.52	1.33	0.00	0.57
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	1.60	1.60	0.00	0.00	0.00	3.19	0.00	4.79	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	1.36	5.44	0.68	0.68	0.68	0.00	0.00	2.04	0.00	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	12.86	1.84	0.00	0.00	0.00	0.00	1.84	0.00	0.00	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	1.67	2.93	0.00	0.42	0.84	2.09	0.00	0.42	0.00	0.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	6.04	2.79	0.93	0.70	0.70	0.46	0.23	1.16	0.93	0.46
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	1.08	2.43	0.27	0.81	0.81	1.08	0.00	1.62	0.00	1.08
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	5.26	3.57	0.21	0.84	0.21	0.63	0.63	1.47	1.68	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11.13	11.13	0.00	0.00	0.00	0.00	11.13	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	1.99	2.48	0.00	0.50	0.00	1.49	0.00	1.99	0.99	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	2.17	5.14	0.00	1.08	1.08	2.17	1.08	1.62	0.27	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	2.49	4.08	0.68	0.23	0.91	0.23	1.13	1.36	0.91	1.13
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	2.61	5.39	0.65	0.33	0.65	0.82	0.82	2.12	0.33	1.14
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	3.28	7.84	0.73	1.46	0.73	1.28	1.64	2.19	1.64	1.09
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	1.59	5.30	0.53	0.00	1.06	0.53	0.00	3.18	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	1.80	3.60	0.00	0.60	0.00	1.80	0.00	2.40	1.80	1.80
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	3.94	5.91	1.64	1.64	1.31	3.61	2.63	0.66	0.33	1.64
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	2.11	6.50	1.14	0.49	0.65	0.33	0.65	3.09	0.65	0.81
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	6.00	10.23	1.06	1.94	0.53	0.88	1.41	5.47	1.59	1.59
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	2.81	2.81	0.70	0.00	0.70	0.00	1.41	3.52	0.70	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	3.22	4.60	0.00	0.46	0.92	0.46	0.92	3.68	1.84	1.84
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	2.25	11.57	0.64	0.96	0.96	1.93	0.64	3.86	1.29	1.29
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	8.62	4.14	2.76	2.76	1.38	0.34	3.45	1.03	3.45	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	12.64	7.59	2.53	2.53	0.00	2.53	5.06	0.00	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	2.67	8.47	1.11	3.12	0.45	1.56	1.34	3.79	2.23	2.01
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	2.96	5.08	0.00	0.42	0.85	0.85	0.42	1.27	0.00	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	3.32	4.03	0.47	0.95	0.71	1.66	0.47	0.71	0.47	1.42
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	2.15	9.87	0.86	0.86	1.29	3.43	0.00	3.43	0.86	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	0.00	9.03	9.03	0.00	9.03	0.00	9.03	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	4.67	17.66	0.67	1.00	1.00	2.33	0.00	9.33	1.67	2.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	2.25	9.02	0.90	0.45	0.00	1.80	0.45	4.06	2.25	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	2.38	10.32	1.59	1.19	1.98	0.00	0.40	3.57	0.40	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	2.79	10.22	0.93	1.86	0.00	0.00	0.00	0.93	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	5.30	6.81	0.00	0.38	1.51	4.16	0.38	2.27	1.89	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	4.56	14.01	1.30	0.98	0.98	0.98	1.63	7.17	1.96	1.30
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	3.49	12.64	0.44	0.44	0.87	0.44	0.00	4.79	0.87	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	5.88	6.78	0.90	1.81	0.90	0.90	0.90	4.07	1.81	1.81
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	4.41	6.17	2.65	0.88	1.76	0.00	0.00	4.41	2.65	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	3.32	4.65	0.66	1.99	1.99	1.33	1.33	3.99	0.00	1.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	2.48	13.39	1.49	0.99	0.99	3.97	0.00	3.47	1.49	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	3.83	20.29	1.15	1.15	2.30	0.77	0.38	6.51	0.38	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	12.40	11.49	3.02	2.72	2.42	0.91	2.12	3.93	2.42	1.21
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	8.40	8.62	2.43	1.77	0.44	2.21	0.66	3.32	1.11	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	5.42	5.42	2.03	2.71	1.36	1.36	0.68	4.74	2.71	2.03
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	10.22	0.00	5.11	0.00	0.00	0.00	0.00	0.00	5.11	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	2.44	15.24	1.83	0.00	1.83	0.61	0.61	3.66	1.22	1.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	4.09	13.22	1.57	1.26	1.26	0.00	0.63	7.55	0.31	1.89
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	5.45	13.01	1.21	0.61	1.21	3.33	0.61	5.15	0.91	1.21
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	6.33	17.41	0.00	1.58	1.58	1.58	0.00	8.70	1.58	2.37
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	15.87	2.27	2.27	2.27	2.27	0.00	0.00	2.27	3.40	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	15.17	0.00	5.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	11.06	9.44	8.07	3.73	2.86	3.98	4.84	0.87	1.99	1.49
Myoblast, donor2	11322-117D8	13.04	7.86	6.14	2.30	3.26	1.34	2.69	2.11	2.69	2.30
Myoblast, donor3	11398-118D3	19.34	11.60	7.23	5.38	5.89	4.88	5.89	3.20	4.54	3.70
NK T cell leukemia cell line:KHYG-1	10777-110G3	52.68	110.62	7.00	13.28	14.45	23.35	8.90	19.41	7.44	1.17
Natural Killer Cells, donor1	11230-116C6	153.14	51.97	10.76	35.98	10.46	5.84	74.42	10.46	12.61	2.46
Natural Killer Cells, donor2	11311-117C6	142.03	29.85	5.73	25.63	3.92	3.92	68.75	10.25	9.65	3.92
Natural Killer Cells, donor3	11387-118C1	136.02	50.06	8.83	20.25	4.97	4.97	51.17	15.28	14.72	3.13
Neural stem cells, donor1	11275-116H6	5.81	2.54	0.00	3.63	1.09	0.36	2.18	0.73	0.36	2.54
Neural stem cells, donor2	11352-117H2	78.95	7.70	0.00	23.11	1.93	0.00	7.70	3.85	11.55	7.70
Neurons, donor1	11494-119E9	38.69	3.41	1.14	6.83	0.00	3.41	0.00	2.28	9.10	3.41
Neurons, donor2	11574-120E8	45.13	3.30	3.30	21.58	1.32	0.66	4.18	1.54	6.83	8.59
Neurons, donor3	11655-122E8	23.84	2.47	2.47	4.11	0.00	0.82	1.64	5.76	0.82	2.47
Neutrophils, donor1	11233-116C9	12.06	2.78	0.00	1.86	0.00	0.00	5.57	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	14.49	0.00	0.00	2.90	0.00	0.00	11.60	2.90	2.90	0.00
Neutrophils, donor3	11390-118C4	15.27	3.05	0.61	4.89	0.61	1.83	8.55	2.44	0.61	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	5.58	6.41	2.37	2.14	1.42	2.26	0.47	3.44	4.99	3.09
Nucleus Pulposus Cell, donor2	11409-118E5	1.30	0.98	0.98	0.98	0.33	0.33	0.00	0.33	0.33	0.98
Nucleus Pulposus Cell, donor3	11462-119B4	7.22	14.24	4.41	1.80	3.61	2.01	0.80	3.41	2.81	2.01
Olfactory epithelial cells, donor1	11933-125I7	12.94	25.05	9.22	3.58	6.19	7.85	2.06	8.40	2.62	1.93
Olfactory epithelial cells, donor2	11934-125I8	21.71	32.86	10.28	4.49	12.01	15.92	4.49	5.21	2.03	2.32
Olfactory epithelial cells, donor3	11935-125I9	21.11	27.35	13.28	4.99	10.44	12.15	5.22	6.92	3.41	3.18
Olfactory epithelial cells, donor4	11936-126A1	19.58	29.12	22.50	6.92	10.62	5.36	3.80	6.23	6.43	3.90
Oligodendrocyte - precursors, donor1	11496-119F2	21.06	14.44	3.61	3.61	4.21	7.22	1.20	3.61	3.01	1.81
Osteoblast - differentiated, donor1	11276-116H7	9.36	5.96	3.19	3.40	0.64	1.06	1.28	2.77	2.13	1.28
Osteoblast - differentiated, donor2	11353-117H3	3.43	4.57	1.14	2.29	0.00	4.57	0.00	0.00	1.14	1.14
Osteoblast - differentiated, donor3	11425-118G3	14.90	4.97	10.55	4.97	3.10	3.10	1.86	5.59	1.86	1.86
Osteoblast, donor1	11277-116H8	2.35	6.06	0.98	0.78	1.76	1.76	0.39	0.78	0.98	0.98
Osteoblast, donor2	11354-117H4	8.43	14.75	4.21	3.51	2.81	1.40	2.11	7.02	2.81	4.21
Osteoblast, donor3	11426-118G4	8.18	5.87	1.96	1.60	1.07	0.89	0.36	2.67	1.78	0.53
Pancreatic stromal cells, donor1	11249-116E7	3.37	3.29	2.36	1.01	1.35	1.01	0.34	1.18	0.42	0.93
Pericytes, donor1	11491-119E6	0.22	0.89	0.00	0.22	0.11	0.11	0.00	0.11	0.00	0.22
Pericytes, donor2	11571-120E5	0.45	0.68	0.23	0.00	0.23	0.00	0.00	0.23	0.00	0.00
Pericytes, donor3	11652-122E5	2.44	10.38	3.05	1.02	1.42	1.42	0.20	1.02	0.81	0.00
Perineurial Cells, donor1	11499-119F5	10.28	14.81	2.26	2.37	4.52	5.99	1.13	6.10	2.26	1.70
Perineurial Cells, donor2	11579-120F4	2.58	2.85	3.40	0.83	2.39	0.55	0.28	1.10	0.46	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	96.26	14.34	5.10	28.05	5.10	2.55	26.46	3.82	14.66	4.78
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	67.09	13.96	2.20	12.73	1.47	2.20	16.41	3.67	11.75	2.94
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	91.11	14.11	2.59	16.57	2.20	2.20	37.01	2.98	10.22	1.68
Placental Epithelial Cells, donor1	11278-116H9	14.59	3.83	2.87	3.11	1.67	1.20	3.11	1.20	0.96	0.72
Placental Epithelial Cells, donor2	11355-117H5	17.74	8.87	7.76	4.44	7.76	1.11	2.22	0.00	2.22	2.22
Placental Epithelial Cells, donor3	11427-118G5	17.47	12.37	4.71	3.73	2.55	4.71	5.50	2.16	1.57	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	12.97	10.76	12.34	3.80	3.80	3.48	3.16	3.16	1.58	1.58
Preadipocyte - breast, donor1	11467-119B9	14.26	21.95	22.89	5.63	9.94	6.57	6.19	4.50	1.13	1.88
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	20.23	46.47	33.28	5.22	19.32	18.93	2.61	8.75	2.09	1.31
Preadipocyte - breast, donor2	11328-117E5	18.91	18.24	15.54	4.05	7.66	3.60	2.93	6.75	2.03	2.03
Preadipocyte - omental, donor1	11468-119C1	20.89	20.99	50.94	11.61	10.55	4.58	9.38	5.54	2.34	1.28
Preadipocyte - omental, donor2	11329-117E6	24.44	35.79	20.51	13.09	11.35	11.35	7.86	3.06	5.24	3.93
Preadipocyte - omental, donor3	11403-118D8	19.63	16.62	19.34	5.87	7.31	2.58	4.01	5.16	2.01	1.58
Preadipocyte - perirenal, donor1	11469-119C2	11.81	5.91	7.87	3.94	1.97	0.00	0.00	1.97	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	1.23	2.15	0.31	0.61	0.00	0.61	0.00	0.92	0.61	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	0.53	0.00	0.35	0.00	0.00	0.00	0.00	0.00	0.18	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	0.68	0.17	0.51	0.17	0.51	0.17	0.00	1.19	0.17	0.00
Preadipocyte - visceral, donor1	11280-116I2	0.56	0.28	0.84	0.00	0.37	0.19	0.19	0.28	0.00	0.09
Preadipocyte - visceral, donor2	11357-117H7	1.38	0.92	1.84	0.46	1.38	0.00	0.00	0.00	0.46	0.46
Preadipocyte - visceral, donor3	11429-118G7	0.31	0.00	0.10	0.10	0.00	0.10	0.00	0.00	0.00	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	42.69	21.87	13.58	7.39	7.84	8.75	9.96	6.03	2.87	1.06
Prostate Epithelial Cells, donor2	11331-117E8	14.76	12.73	4.20	4.87	4.33	3.93	3.52	4.60	3.39	2.17
Prostate Epithelial Cells, donor3	11404-118D9	38.70	29.52	13.66	9.68	9.37	7.78	4.04	4.59	4.29	1.35
Prostate Stromal Cells, donor1	11254-116F3	13.78	22.44	37.70	5.70	10.36	4.90	4.56	3.42	3.19	0.80
Prostate Stromal Cells, donor2	11332-117E9	17.21	31.02	10.58	5.56	9.14	14.70	5.92	4.30	2.51	0.54
Prostate Stromal Cells, donor3	11405-118E1	9.80	14.08	17.62	2.50	4.59	1.46	3.75	3.44	1.25	0.63
Renal Cortical Epithelial Cells, donor1	11516-119H4	9.12	8.76	0.36	1.09	1.46	2.92	0.36	2.55	2.19	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	18.44	20.93	2.36	4.51	1.87	6.24	3.12	5.20	4.37	2.91
Renal Epithelial Cells, donor1	11517-119H5	3.04	1.52	0.00	0.51	0.51	0.00	1.01	0.51	2.03	0.51
Renal Epithelial Cells, donor2	11597-120H4	2.13	4.27	0.71	0.00	0.00	4.27	2.13	1.42	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	17.68	13.13	3.39	4.23	2.96	4.34	1.69	4.13	5.40	4.13
Renal Glomerular Endothelial Cells, donor1	11514-119H2	2.04	2.04	2.04	2.72	0.00	0.00	1.36	0.00	0.68	1.36
Renal Glomerular Endothelial Cells, donor2	11594-120H1	2.70	9.30	5.66	0.67	4.04	2.56	0.40	1.75	1.08	0.54
Renal Glomerular Endothelial Cells, donor3	11675-122H1	13.99	9.55	7.55	2.44	4.22	2.44	2.44	3.33	2.66	1.55
Renal Glomerular Endothelial Cells, donor4	11783-124B1	1.33	0.67	0.00	0.67	0.00	0.00	0.67	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	3.74	1.98	0.22	0.44	1.54	0.88	0.66	1.10	0.88	1.32
Renal Mesangial Cells, donor2	11598-120H5	1.88	3.76	0.63	0.00	0.00	1.25	1.25	3.13	1.88	0.63
Renal Mesangial Cells, donor3	11679-122H5	1.11	0.55	0.00	0.00	0.00	0.83	0.00	1.66	0.28	0.83
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	16.37	20.67	3.49	4.29	4.56	5.64	1.34	3.22	2.95	2.15
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	11.81	21.08	1.27	1.27	2.11	1.69	0.84	1.69	0.42	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	6.75	6.75	0.19	1.74	0.96	2.51	1.16	1.74	1.16	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	7.78	2.07	1.30	0.26	1.56	1.30	1.30	0.52	1.56	1.81
Retinal Pigment Epithelial Cells, donor1	11528-119I7	3.70	5.12	1.14	0.57	1.14	0.28	0.28	1.99	0.85	0.85
Retinal Pigment Epithelial Cells, donor2	11608-120I6	0.00	0.00	1.03	0.00	0.00	1.03	0.00	0.00	2.06	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	15.31	36.38	10.79	7.78	11.54	10.79	2.01	4.52	6.02	4.52
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	26.73	12.03	5.48	5.35	4.94	2.94	12.83	3.21	2.81	0.80
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	23.23	38.42	1.79	8.93	5.36	8.04	6.25	7.15	2.68	1.79
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	30.82	42.93	6.05	12.66	6.05	20.36	4.95	4.95	2.20	1.65
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	26.10	22.62	2.90	8.12	4.64	9.86	2.90	3.48	4.06	6.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	26.40	13.39	2.08	6.89	1.17	2.86	4.03	2.73	2.34	2.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	23.34	11.92	1.19	5.26	1.49	5.16	6.16	4.37	2.18	1.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	27.55	17.73	0.89	10.37	2.34	6.92	9.15	5.02	3.79	3.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	34.48	14.89	1.49	6.70	2.11	6.08	5.71	4.34	2.98	3.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	21.56	17.48	1.75	6.18	2.91	5.94	4.66	5.36	2.68	2.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	29.58	17.57	1.39	7.17	2.77	6.24	6.24	5.32	2.77	2.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	25.88	14.51	0.55	3.70	1.51	3.01	2.74	2.74	2.88	2.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	23.45	14.67	2.12	5.90	3.03	5.75	6.66	4.24	2.12	3.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	28.67	13.44	0.72	10.75	1.97	5.73	9.50	3.23	1.97	3.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	26.83	11.76	1.00	5.16	2.44	2.15	2.87	4.73	3.16	1.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	23.93	12.99	0.97	4.40	2.47	4.29	5.15	4.29	2.25	1.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	27.66	14.83	1.11	9.07	1.33	6.42	9.29	3.98	2.21	1.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	26.00	10.90	0.76	4.78	1.15	2.87	2.68	4.01	3.44	2.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	21.80	14.35	1.30	6.24	1.77	5.59	4.29	5.50	2.14	3.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	33.07	25.93	1.88	13.72	4.51	6.58	11.65	7.14	2.82	3.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	22.96	13.67	1.06	3.72	2.52	1.86	3.18	3.72	1.33	2.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	24.63	15.48	1.17	6.23	1.17	3.89	6.42	5.06	2.53	2.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	24.25	16.04	1.72	9.36	4.39	6.11	6.49	4.77	2.29	2.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	25.95	12.60	1.17	6.73	2.03	3.20	3.20	2.56	1.92	2.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	22.14	12.89	1.68	8.13	3.64	4.20	5.33	4.77	1.40	1.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	26.83	17.60	1.88	8.03	2.05	5.47	5.81	4.61	2.22	1.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	21.51	13.67	1.09	4.92	2.92	2.37	2.19	2.37	1.46	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	25.63	13.73	0.98	4.29	1.84	5.15	5.27	3.31	1.84	2.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	28.07	14.10	0.94	6.58	1.61	4.57	5.78	4.03	2.42	2.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	29.72	13.44	2.59	7.08	3.77	2.36	3.54	2.83	1.89	2.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	23.02	13.89	1.98	7.54	1.39	6.55	4.96	4.96	1.59	1.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	23.85	16.60	0.70	8.89	2.10	5.61	5.61	5.38	1.87	1.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	26.96	14.10	1.87	6.64	4.56	1.87	2.07	3.32	1.87	1.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	24.33	15.48	3.10	8.41	2.43	7.08	8.41	4.87	1.11	3.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	27.15	11.91	0.63	4.60	1.88	4.80	5.01	4.18	2.72	2.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	26.92	12.65	1.08	4.98	1.75	2.83	3.10	2.96	3.36	2.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	19.58	12.26	1.02	4.43	1.70	4.43	3.75	5.62	2.21	2.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	22.75	10.60	1.74	5.78	1.35	4.82	5.01	4.43	1.35	1.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	22.87	6.71	1.20	4.99	1.55	2.24	2.58	2.06	2.41	1.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	17.56	10.29	1.10	4.12	0.96	4.12	4.94	2.47	1.92	1.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	17.73	9.19	0.49	5.42	1.31	5.75	2.96	4.10	1.81	1.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	22.50	8.18	0.85	4.26	1.19	1.53	3.58	1.36	3.24	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	20.57	7.55	0.74	4.29	1.48	3.55	4.29	3.55	3.26	2.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	23.72	10.40	0.53	5.60	0.80	2.93	4.00	2.40	2.40	1.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	39.54	33.46	2.07	6.64	5.12	6.08	3.04	8.85	3.46	3.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	14.76	8.10	0.71	4.29	0.71	5.24	2.14	1.90	1.19	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	20.96	10.28	1.81	7.05	1.61	5.64	5.44	2.62	1.61	2.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	26.65	14.50	1.04	4.24	3.58	4.24	2.64	2.73	1.51	2.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	37.03	35.63	2.45	14.32	4.89	10.48	5.59	9.08	2.45	2.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	35.66	28.71	2.12	11.79	3.02	4.84	4.23	6.65	3.02	3.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	22.52	9.91	0.86	4.16	2.45	2.45	1.84	1.35	1.71	2.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	73.65	81.65	6.40	29.69	15.57	26.05	11.94	14.12	6.70	4.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	50.50	40.76	3.04	12.17	9.73	10.95	6.69	7.91	4.87	3.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	28.93	8.44	1.21	5.12	3.92	1.81	2.71	2.71	0.90	3.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	39.13	46.59	3.17	11.54	8.37	15.61	6.11	7.69	2.71	2.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	41.64	40.74	2.10	14.38	6.59	16.18	4.79	10.18	3.59	4.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	48.17	38.73	2.72	12.75	8.74	11.57	4.49	7.08	3.66	3.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	37.57	42.26	2.13	11.31	8.32	13.66	7.04	8.75	3.84	3.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	43.87	44.47	4.21	7.81	6.61	14.42	3.61	10.22	3.61	3.00
Schwann Cells, donor1	11498-119F4	0.38	2.82	0.56	0.38	1.32	0.19	0.19	1.13	0.00	0.00
Schwann Cells, donor2	11578-120F3	0.00	17.01	3.40	0.00	0.00	0.00	0.00	6.80	3.40	3.40
Schwann Cells, donor3	11659-122F3	5.04	5.92	1.53	1.31	1.75	2.63	1.10	3.29	2.41	0.88
Sebocyte, donor1	11220-116B5	27.39	21.91	2.74	6.57	7.12	6.03	4.93	2.74	6.57	1.64
Sebocyte, donor2	11301-117B5	12.87	12.41	5.06	2.76	3.68	4.14	1.38	2.30	1.84	0.92
Sebocyte, donor3	11378-118B1	5.15	3.30	2.47	1.24	0.00	0.82	0.41	0.41	1.24	0.00
Sertoli Cells, donor1	11255-116F4	9.94	36.45	9.94	3.31	9.94	6.63	0.00	3.31	0.00	1.66
Sertoli Cells, donor2	11333-117F1	5.65	14.12	2.82	2.82	0.00	2.82	0.00	2.82	0.00	2.82
Skeletal Muscle Cells, donor1	11281-116I3	10.03	36.33	3.52	3.08	7.13	14.25	1.32	5.89	3.43	3.26
Skeletal Muscle Cells, donor2	11358-117H8	2.89	2.89	2.17	1.45	0.00	0.00	2.89	0.00	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	1.67	0.00	0.84	1.67	2.51	0.84	0.00	1.67	0.84	0.84
Skeletal Muscle Cells, donor4	11451-119A2	5.18	11.78	2.36	1.10	3.14	3.14	0.79	1.26	3.77	1.10
Skeletal Muscle Cells, donor5	11455-119A6	5.35	16.50	1.34	2.23	3.57	4.01	0.74	2.53	1.34	2.23
Skeletal Muscle Cells, donor6	11459-119B1	6.31	7.39	4.62	1.54	5.08	1.85	1.08	2.62	2.15	1.85
Skeletal Muscle Satellite Cells, donor1	11240-116D7	6.55	16.63	4.54	2.65	5.04	6.80	1.26	4.66	3.91	3.15
Skeletal Muscle Satellite Cells, donor2	11321-117D7	3.14	5.14	2.43	1.00	0.71	0.71	0.00	2.28	1.71	1.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	8.04	14.29	3.67	2.68	2.98	4.76	0.99	3.97	3.08	1.98
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	6.91	22.83	3.45	2.78	3.62	7.25	1.43	4.47	1.10	1.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	6.51	13.03	2.17	0.72	4.34	2.90	0.00	3.62	1.45	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	1.24	2.61	1.24	0.00	0.69	0.69	0.41	0.83	0.28	0.69
Skin - palm, donor1	10286-104F7	21.49	2.69	0.00	0.00	0.00	0.00	2.69	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	12.97	13.26	1.30	4.32	1.73	3.75	2.02	2.88	2.59	2.02
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	72.79	72.79	8.18	28.63	9.00	15.54	7.36	13.09	13.09	9.81
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	13.50	11.94	2.47	4.15	4.54	4.15	1.95	4.02	2.86	1.04
Small Airway Epithelial Cells, donor1	11256-116F5	39.20	55.46	7.92	15.99	12.65	21.82	8.62	5.14	6.12	3.75
Small Airway Epithelial Cells, donor2	11334-117F2	40.09	51.62	5.49	9.14	7.17	15.47	6.75	6.89	7.03	2.39
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	65.34	50.96	12.69	21.36	21.99	16.07	9.09	14.38	13.74	4.44
Small Airway Epithelial Cells, donor3	11406-118E2	41.22	34.33	8.39	13.34	8.09	10.79	3.82	6.37	5.47	2.25
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	5.55	3.09	0.62	1.54	0.31	0.31	0.62	0.31	0.62	1.23
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	12.90	32.68	24.01	3.33	14.45	3.11	0.44	4.00	0.89	1.33
Smooth Muscle Cells - Aortic, donor0	11210-116A4	3.53	1.18	0.00	0.59	2.35	0.59	0.59	2.35	2.94	1.76
Smooth Muscle Cells - Aortic, donor1	11283-116I5	2.21	9.50	3.09	0.66	2.21	4.20	1.10	1.99	0.66	0.88
Smooth Muscle Cells - Aortic, donor2	11360-117I1	1.58	1.97	0.39	0.79	0.00	0.39	0.00	0.79	0.39	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	1.55	2.32	0.77	0.77	0.00	1.55	0.77	1.55	0.00	2.32
Smooth Muscle Cells - Bladder, donor1	11519-119H7	1.00	1.00	1.00	2.00	1.00	2.00	0.00	4.00	2.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	2.40	8.52	0.40	1.33	0.93	1.60	0.67	2.79	0.40	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	4.65	2.44	3.10	0.89	1.33	1.55	0.66	0.89	0.22	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	14.60	19.84	9.47	3.46	6.53	5.38	2.69	4.99	1.79	1.79
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	5.21	8.14	4.56	2.60	4.88	1.30	0.33	2.60	1.30	1.30
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	7.09	8.27	1.48	2.07	1.77	2.66	1.18	2.95	2.66	3.54
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	3.84	4.13	0.85	0.71	0.71	1.85	0.14	2.28	1.00	1.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	1.46	2.44	0.49	0.16	0.16	0.98	0.00	0.33	0.65	0.49
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	10.96	27.40	12.18	3.04	3.96	5.78	0.61	5.78	4.57	2.44
Smooth Muscle Cells - Carotid, donor1	11285-116I7	0.76	1.26	0.25	0.00	0.00	0.51	0.25	0.00	0.25	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	18.36	12.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	5.72	4.77	1.91	0.00	0.95	1.43	0.48	0.00	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	5.75	11.80	1.62	1.62	2.21	2.95	0.88	3.98	1.92	2.36
Smooth Muscle Cells - Colonic, donor2	11320-117D6	8.18	15.50	4.95	2.37	4.74	2.37	1.29	3.87	1.72	1.94
Smooth Muscle Cells - Colonic, donor3	11396-118D1	8.92	15.85	3.88	2.94	4.09	4.62	1.26	4.51	1.36	1.57
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	1.55	3.56	2.01	0.46	2.01	0.77	0.62	0.62	0.15	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	1.08	5.39	2.16	0.00	2.16	2.16	0.00	1.08	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	4.18	2.99	2.09	1.49	1.79	0.60	0.00	1.79	0.90	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	1.02	4.78	0.00	0.00	0.34	0.68	0.34	0.34	0.68	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	5.26	15.86	5.26	2.04	2.67	4.87	0.86	6.99	3.77	4.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	8.35	7.95	2.11	2.42	1.91	2.42	1.21	2.82	2.31	2.92
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	3.19	2.50	1.14	0.91	0.91	0.46	0.68	2.96	0.68	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	1.81	4.83	1.81	2.42	0.00	0.60	1.21	0.60	1.81	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	13.25	16.69	11.92	4.24	12.72	6.36	4.24	6.09	5.56	3.44
Smooth Muscle Cells - Prostate, donor1	11257-116F6	7.32	5.59	2.53	0.93	1.86	1.46	1.60	1.07	1.60	0.40
Smooth Muscle Cells - Prostate, donor2	11335-117F3	8.39	15.15	15.40	2.00	5.76	2.38	1.50	3.76	2.50	2.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	4.06	4.31	0.25	1.78	0.25	0.51	0.76	1.01	0.51	1.27
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	4.07	3.02	3.92	0.75	1.36	1.96	1.36	1.51	1.96	0.90
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	1.50	4.50	1.50	0.00	0.75	0.00	0.00	0.00	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	5.17	3.88	7.75	1.29	6.46	12.92	0.00	2.58	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	0.00	1.86	0.00	0.47	0.00	1.40	0.00	1.86	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	3.53	9.09	3.03	2.02	1.51	1.51	0.50	1.51	1.51	1.51
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	5.64	9.09	3.76	0.63	3.76	0.94	1.25	2.82	1.25	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	0.59	0.59	0.59	0.00	0.00	0.29	0.00	0.00	0.29	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	7.33	7.25	6.58	1.42	3.67	4.50	1.08	1.75	3.00	2.58
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	3.27	2.80	1.40	0.00	1.40	1.87	0.00	0.93	0.93	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	4.03	5.61	1.58	0.86	1.44	1.30	0.58	1.58	0.86	1.15
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	5.35	4.84	2.80	0.76	1.02	2.80	0.25	3.31	1.27	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	2.82	5.45	1.69	0.38	1.13	1.13	1.13	1.32	0.56	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	11.18	12.58	4.05	3.63	5.31	5.59	1.54	4.33	4.61	2.93
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	10.56	19.10	4.11	3.35	3.60	4.69	0.59	4.52	4.19	2.43
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	0.95	0.95	0.00	0.00	0.48	0.48	0.00	0.48	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	4.16	6.85	1.71	1.96	1.22	0.98	0.00	1.47	0.98	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	5.74	8.40	3.31	0.88	2.65	1.55	1.55	1.10	0.66	0.66
Smooth Muscle Cells - Uterine, donor3	11466-119B8	11.41	7.31	7.61	3.22	4.97	2.63	1.76	3.51	1.46	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	5.83	4.66	0.39	1.17	1.55	0.78	0.00	2.14	1.36	0.97
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	6.35	4.50	3.17	1.32	2.12	1.32	0.53	0.79	0.26	0.79
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	4.46	3.72	4.09	1.49	1.86	4.09	1.86	1.12	2.60	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	6.11	6.47	1.80	1.44	2.87	1.44	2.16	1.44	0.72	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	12.78	13.63	3.12	3.41	2.27	2.56	2.27	2.84	1.42	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	10.63	18.91	8.67	4.33	5.51	3.94	3.94	2.36	1.58	1.18
Smooth muscle cells - airway, control, donor1	11966-126D4	6.35	7.36	2.29	1.52	1.02	0.25	0.76	3.30	1.02	0.76
Smooth muscle cells - airway, control, donor2	11967-126D5	5.19	4.39	1.20	0.80	0.00	0.40	0.00	2.40	1.20	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	7.11	3.76	2.51	0.84	0.42	0.00	0.00	1.25	1.25	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	10.08	2.75	2.29	0.92	3.21	0.46	0.46	3.67	0.00	0.46
Synoviocyte, donor1	11291-117A4	7.24	13.97	1.85	3.87	1.18	4.04	1.01	2.69	2.36	2.36
Synoviocyte, donor2	11368-117I9	7.71	6.70	8.05	3.52	2.51	1.34	2.01	1.84	1.68	1.51
Synoviocyte, donor3	11440-118H9	2.01	1.34	0.67	0.45	0.45	0.22	0.00	1.34	0.22	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	2.50	7.86	1.79	0.71	1.43	1.79	0.00	2.14	1.43	0.71
Trabecular Meshwork Cells, donor2	11612-122A1	7.93	21.80	5.95	0.00	3.96	1.98	0.00	1.98	3.96	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	4.86	13.20	3.47	1.85	2.08	3.70	0.23	1.85	2.08	1.16
Tracheal Epithelial Cells, donor1	11292-117A5	15.05	24.59	13.05	5.81	10.82	6.81	3.15	4.16	3.80	1.43
Tracheal Epithelial Cells, donor2	11369-118A1	11.21	5.41	1.55	4.64	1.16	1.93	2.32	1.55	0.77	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	9.16	20.04	2.29	3.44	2.86	4.01	2.29	2.29	0.00	1.15
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	24.97	10.83	4.31	7.63	6.40	4.31	11.32	2.21	2.09	0.49
Urethra, donor2	10319-105A4	7.19	3.60	7.19	5.40	0.00	1.80	1.80	0.00	1.80	0.00
Urothelial Cells, donor1	11520-119H8	4.78	9.83	1.33	0.27	1.06	1.86	0.53	2.92	1.86	0.80
Urothelial Cells, donor2	11600-120H7	4.41	3.20	2.00	0.80	2.40	0.80	1.20	0.80	1.20	0.40
Urothelial Cells, donor3	11681-122H7	4.81	4.58	0.00	1.15	1.15	0.46	0.23	0.69	0.69	0.69
Urothelial cells, donor0	11216-116B1	29.65	26.08	2.90	7.13	4.46	8.92	2.45	5.57	5.13	3.57
Whole blood (ribopure), donor090309, donation1	12179-129A1	40.93	9.79	0.89	7.12	1.78	1.78	0.89	1.78	7.12	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	57.18	8.58	2.86	11.44	1.43	4.29	4.29	2.86	7.15	2.86
Whole blood (ribopure), donor090309, donation3	12181-129A3	23.27	5.48	2.05	7.53	0.00	2.74	2.74	0.68	3.42	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	48.55	9.30	1.03	15.50	1.72	2.07	7.23	1.38	8.26	3.44
Whole blood (ribopure), donor090325, donation2	12177-128I8	37.77	5.23	0.58	18.59	0.58	4.07	6.39	1.74	6.97	4.65
Whole blood (ribopure), donor090612, donation1	12182-129A4	38.53	6.25	0.00	8.33	3.12	1.04	4.16	0.00	10.41	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	38.55	4.59	0.92	12.85	5.51	0.00	4.59	0.00	11.01	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	37.43	3.65	2.74	4.56	3.65	2.74	5.48	1.83	9.13	0.00
Wilms' tumor cell line:G-401	10809-111A8	13.32	8.39	7.28	2.10	4.44	4.19	6.04	3.08	1.85	1.23
Wilms' tumor cell line:HFWT	10597-108E3	24.64	29.92	24.64	4.40	1.76	7.92	4.40	6.16	4.40	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	29.33	15.92	2.79	4.75	3.35	5.87	8.38	1.96	3.35	1.96
achilles tendon, donor2	10292-104G4	0.00	6.20	0.00	2.07	0.00	0.00	4.13	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	51.25	39.26	2.80	11.73	5.35	7.14	17.85	6.88	6.88	7.14
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	57.35	23.45	2.09	9.98	3.71	4.64	4.41	8.59	5.57	8.36
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	50.61	9.80	2.72	16.05	4.90	4.08	7.07	5.44	6.53	3.81
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	22.21	49.19	3.94	9.56	6.18	14.90	4.78	5.06	3.94	6.46
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	18.61	15.65	14.38	7.61	7.82	6.56	7.19	5.71	2.96	1.90
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	147.54	213.41	45.73	39.74	57.44	83.02	46.82	30.49	14.16	7.62
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	10.13	22.91	3.97	4.85	3.08	5.73	0.88	4.41	3.53	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	39.61	29.81	5.72	17.97	8.17	7.35	2.45	4.90	7.76	2.45
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	9.32	3.11	0.00	5.44	0.39	0.78	0.39	1.55	1.55	1.55
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	23.18	25.76	3.31	11.04	7.73	6.81	2.39	5.15	4.23	1.10
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	19.50	15.60	0.00	11.70	0.00	3.90	7.80	7.80	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	37.65	36.72	7.44	9.30	9.53	17.66	14.18	5.11	3.95	3.02
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	19.42	11.91	3.11	8.54	2.07	2.07	4.14	4.14	2.59	1.55
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	7.01	4.97	1.17	2.05	0.88	1.17	0.88	2.63	1.46	1.46
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	4.18	2.32	0.00	0.93	0.93	0.46	0.00	0.46	0.46	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	23.03	35.37	0.82	11.10	3.70	6.17	2.06	7.81	2.06	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	8.59	18.11	2.15	1.23	3.07	5.83	0.61	5.83	0.00	2.46
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	24.75	26.46	5.55	16.64	7.68	15.36	2.99	10.67	5.55	1.71
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	20.62	26.99	5.16	11.83	5.16	7.58	3.64	4.85	4.55	3.34
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	27.44	32.98	9.39	14.44	15.41	13.48	5.05	8.18	5.54	3.13
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	25.39	16.04	4.01	13.81	6.01	3.12	3.12	5.12	6.46	3.12
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	17.34	33.35	4.67	4.00	6.67	13.01	6.34	7.67	3.67	1.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	7.43	9.29	0.00	1.86	0.00	3.72	0.00	1.86	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	0.00	1.13	0.00	0.00	0.00	1.51	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	8.29	10.47	9.59	0.87	7.41	3.49	1.31	0.87	0.44	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	0.00	3.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	41.68	14.13	13.66	8.95	8.71	3.06	3.06	4.24	3.53	2.35
adipose tissue, adult, pool1	10010-101C1	4.65	2.02	2.95	2.02	2.17	0.47	0.78	0.62	0.93	0.47
adipose, donor1	10184-103D4	47.50	2.35	7.04	9.38	1.17	1.76	7.62	2.35	2.35	1.17
adipose, donor2	10185-103D5	9.33	8.11	2.43	1.62	2.03	0.81	0.41	1.62	0.00	0.81
adipose, donor3	10186-103D6	16.88	12.25	3.54	3.81	2.45	1.36	3.27	6.53	1.36	0.82
adipose, donor4	10187-103D7	28.60	17.34	5.20	6.93	3.47	3.47	6.07	5.20	1.73	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	17.99	3.16	2.84	3.47	5.37	3.47	2.21	1.26	2.68	1.74
adrenal gland, adult, pool1	10081-102A9	3.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	28.95	11.07	15.88	7.20	15.21	7.47	2.40	2.27	6.54	5.47
alveolar cell carcinoma cell line:SW 1573	10708-109H6	16.44	11.79	13.22	3.57	15.72	5.72	4.29	3.57	1.43	2.86
amniotic membrane cells, donor1	12235-129G3	66.31	4.17	10.20	7.88	10.67	5.33	9.27	1.62	1.85	3.48
amniotic membrane cells, donor2	12236-129G4	59.51	11.83	15.89	7.44	5.07	6.09	24.68	5.41	6.42	3.38
amniotic membrane cells, donor3	12237-129G5	63.93	5.01	15.02	5.60	12.67	7.07	6.19	1.18	2.95	2.36
amygdala - adult, donor10196	10167-103B5	47.43	2.37	0.00	7.11	0.00	0.00	3.56	3.56	8.30	4.74
amygdala, adult, donor10252	10151-102I7	24.94	1.42	1.42	5.27	0.20	0.81	3.85	2.64	7.71	8.11
amygdala, newborn, donor10223	10360-105E9	16.46	2.26	1.29	7.10	0.97	1.29	3.23	0.65	2.58	6.46
anaplastic carcinoma cell line:8305C	10428-106D5	22.79	35.02	4.71	8.53	5.73	8.53	1.15	8.91	7.00	3.82
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	35.96	47.88	5.07	12.58	5.96	8.60	7.72	9.49	4.19	3.09
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	0.00	0.67	0.00	0.00	0.33	0.33	0.00	0.33	0.00	0.00
aorta, adult, pool1	10052-101G7	16.48	2.55	1.77	2.94	0.39	0.98	1.18	1.57	2.16	2.55
appendix, adult	10189-103D9	26.78	8.54	7.76	9.31	1.94	1.16	7.76	4.27	6.21	4.27
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
artery, adult	10190-103E1	32.61	1.36	9.51	10.87	1.36	0.00	0.00	1.36	2.72	0.00
astrocytoma cell line:TM-31	10425-106D2	31.29	27.38	3.77	11.01	4.78	6.81	3.33	10.58	5.07	4.06
b cell line:RPMI1788	10427-106D4	45.06	33.31	3.42	6.39	3.72	6.99	10.26	13.68	2.53	2.08
basal cell carcinoma cell line:TE 354.T	10702-109G9	13.04	11.10	2.50	3.61	3.05	2.50	0.83	4.99	1.66	1.66
bile duct carcinoma cell line:HuCCT1	10432-106D9	40.49	99.53	18.26	10.42	19.05	28.68	5.85	16.77	7.05	5.16
bile duct carcinoma cell line:TFK-1	10496-107C1	64.61	53.39	35.65	19.92	30.96	19.58	6.53	9.37	3.18	0.50
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	7.27	10.63	0.00	2.24	0.00	0.56	0.00	2.80	0.56	0.00
bladder, adult, pool1	10011-101C2	16.95	3.15	3.04	6.08	1.30	1.63	1.41	1.09	2.93	1.63
blood, adult, pool1	10053-101G8	39.86	6.64	2.21	6.64	6.64	0.00	0.00	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	5.99	2.57	0.00	1.71	0.00	0.86	0.00	0.00	0.86	0.00
bone marrow, adult	10192-103E3	2.02	0.67	1.35	0.00	0.67	0.00	1.35	0.67	0.00	0.00
brain, adult, donor1	10084-102B3	26.65	1.03	1.03	3.08	0.00	0.00	2.05	0.00	4.10	4.10
brain, adult, pool1	10012-101C3	35.52	0.89	1.45	7.35	0.22	0.45	4.34	1.45	8.02	8.13
brain, fetal, pool1	10085-102B4	29.39	0.00	0.00	5.34	0.00	0.00	2.67	0.00	5.34	8.01
breast carcinoma cell line:MCF7	10482-107A5	68.06	49.55	29.73	17.51	15.86	24.78	62.44	8.92	11.23	4.29
breast carcinoma cell line:MDA-MB-453	10419-106C5	101.61	12.11	8.99	20.47	6.37	6.24	44.56	4.12	15.23	5.62
breast, adult, donor1	10080-102A8	6.31	3.79	1.26	1.89	0.63	1.26	0.00	0.63	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	57.80	16.26	8.00	14.99	24.14	19.44	6.35	11.81	8.89	4.19
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	17.32	7.42	3.71	1.55	5.26	3.40	2.47	3.40	2.16	3.71
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	7.14	2.30	1.61	1.61	0.92	1.61	0.46	1.15	0.92	0.92
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	135.33	33.89	30.74	38.01	22.03	19.61	27.36	10.65	15.98	9.68
carcinoid cell line:NCI-H1770	10703-109H1	38.08	19.28	1.41	7.05	0.94	3.29	2.82	3.76	7.05	1.41
carcinoid cell line:NCI-H727	10735-110B6	32.49	25.70	17.17	5.47	10.06	6.34	7.44	3.94	1.86	1.09
carcinoid cell line:SK-PN-DW	10719-109I8	18.70	2.54	0.95	5.70	0.95	1.58	0.63	3.17	2.85	0.95
carcinosarcoma cell line:JHUCS-1	10642-109A3	19.43	46.58	13.58	2.66	15.97	18.10	4.53	19.43	7.45	10.65
caudate nucleus - adult, donor10196	10177-103C6	50.66	2.30	0.00	4.61	1.15	1.15	3.45	1.15	2.30	5.76
caudate nucleus, adult, donor10252	10164-103B2	24.76	0.50	0.33	4.69	0.17	0.00	0.67	0.50	4.18	3.68
caudate nucleus, adult, donor10258	10379-105H1	35.91	0.76	2.29	5.35	0.00	0.00	3.06	0.00	1.53	10.70
caudate nucleus, newborn, donor10223	10354-105E3	29.30	4.03	2.56	11.72	0.37	0.00	3.66	4.03	4.39	5.86
cerebellum - adult, donor10196	10173-103C2	110.70	5.83	11.65	20.39	5.83	8.74	14.57	8.74	14.57	23.31
cerebellum, adult, donor10252	10166-103B4	66.83	4.70	11.53	14.52	1.92	2.56	10.03	3.42	16.65	22.42
cerebellum, adult, pool1	10083-102B2	44.50	4.48	10.69	4.14	4.14	2.07	6.55	3.10	10.69	12.07
cerebellum, newborn, donor10223	10357-105E6	48.99	10.79	15.78	26.57	5.81	6.64	4.15	4.15	4.15	17.44
cerebral meninges, adult	10188-103D8	24.46	0.50	3.03	6.30	0.00	0.25	4.03	1.51	8.57	9.83
cerebrospinal fluid, donor2	10294-104G6	5.12	1.46	1.46	4.39	1.46	0.00	1.46	1.46	0.73	3.65
cervical cancer cell line:D98-AH2	10552-107I3	60.10	38.25	66.14	20.99	38.97	19.12	3.31	7.33	9.20	3.74
cervical cancer cell line:ME-180	10553-107I4	76.73	42.09	50.21	20.38	31.82	13.26	11.43	8.45	7.79	2.65
cervix, adult, pool1	10013-101C4	15.33	2.94	5.67	4.93	2.41	0.73	1.89	2.31	3.25	2.83
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	32.19	62.42	34.70	15.05	14.07	9.20	6.97	7.38	4.60	1.67
chondrosarcoma cell line:SW 1353	10700-109G7	2.61	1.31	0.00	0.00	0.00	0.00	0.00	1.31	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	71.46	108.12	12.92	27.84	19.01	20.38	22.25	15.53	4.97	1.12
choriocarcinoma cell line:SCH	10785-110H2	98.08	107.07	8.01	13.18	13.80	22.06	27.23	22.55	3.33	0.49
choriocarcinoma cell line:T3M-3	10618-108G6	43.64	56.92	2.13	8.30	8.30	8.78	7.83	19.69	4.03	1.19
chorionic membrane cells, donor1	12238-129G6	58.69	10.83	9.97	4.27	9.97	8.83	7.12	1.99	1.42	1.14
chorionic membrane cells, donor2	12239-129G7	35.50	15.71	6.07	3.78	7.36	6.76	5.47	3.08	1.69	0.60
chorionic membrane cells, donor3	12240-129G8	64.29	25.83	17.03	7.69	14.84	9.34	11.54	3.30	2.20	1.65
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	21.21	4.04	2.02	10.10	0.00	0.00	0.00	2.02	5.05	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	15.18	18.06	13.64	5.96	13.83	5.19	2.88	2.69	2.31	1.15
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	0.63	0.63	0.21	0.00	0.21	0.00	0.21	0.00	0.21	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	17.21	15.41	7.45	3.85	12.58	4.88	1.03	4.88	1.03	0.51
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	15.72	13.30	7.50	5.08	9.43	9.19	2.42	2.90	1.45	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	14.46	16.70	11.40	6.31	10.99	8.96	0.81	3.05	1.22	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	19.43	25.91	15.02	12.37	24.73	15.31	2.36	6.18	2.94	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	4.17	7.82	3.91	1.04	2.35	4.17	1.82	1.56	1.56	0.78
clear cell carcinoma cell line:JHOC-5	10638-108I8	26.06	15.09	4.11	5.26	5.94	9.37	4.11	7.77	4.11	4.57
clear cell carcinoma cell line:TEN	10636-108I6	42.34	31.23	18.91	10.58	17.70	14.75	9.37	11.62	6.94	4.86
colon carcinoma cell line:CACO-2	10513-107D9	61.50	36.97	15.01	13.00	17.02	14.64	14.83	13.73	3.48	1.83
colon carcinoma cell line:COLO-320	10420-106C6	77.54	61.19	7.98	21.28	9.50	11.78	9.12	23.57	8.74	4.18
colon, adult, donor1	10082-102B1	22.61	2.38	7.14	4.76	3.57	0.00	1.19	3.57	2.38	2.38
colon, adult, pool1	10014-101C5	21.15	4.11	1.88	8.11	2.70	1.53	2.35	2.12	4.23	3.17
colon, fetal, donor1	10070-101I7	22.25	3.09	3.09	3.71	2.47	0.62	1.24	3.09	2.47	0.62
common myeloid progenitor CMP, donor1	12130-128D6	18.33	0.00	0.00	4.58	0.00	0.00	0.00	9.17	4.58	9.17
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	25.04	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	33.14	58.64	7.65	14.87	19.55	43.34	7.22	18.70	2.55	2.97
cord blood derived cell line:COBL-a 24h infection	10453-106G3	27.17	42.26	7.40	8.60	17.66	44.68	9.66	11.77	1.21	2.87
cord blood derived cell line:COBL-a untreated	10449-106F8	28.34	40.05	8.74	8.04	13.96	37.09	8.74	9.73	2.26	1.69
corpus callosum, adult, pool1	10042-101F6	47.54	3.21	2.99	8.29	0.77	1.33	11.61	1.55	9.95	8.51
cruciate ligament, donor2	10295-104G7	7.29	4.05	4.86	1.62	1.62	0.00	4.05	1.62	1.62	0.00
diaphragm, fetal, donor1	10069-101I6	16.85	4.01	0.80	2.41	1.61	0.80	0.80	1.61	0.00	2.41
diencephalon, adult	10193-103E4	29.04	3.84	2.16	4.56	1.20	0.96	4.56	0.72	6.24	6.72
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	45.92	41.56	5.28	8.73	8.27	7.58	12.86	8.73	7.12	8.73
ductal cell carcinoma cell line:KLM-1	10438-106E6	38.98	59.75	3.08	14.36	5.13	20.77	2.82	15.64	6.92	6.67
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	13.96	28.41	40.44	5.78	12.52	6.74	5.06	5.30	3.85	1.69
ductus deferens, adult	10196-103E7	38.37	10.47	29.90	6.98	13.95	4.49	9.47	2.99	3.99	7.48
duodenum, fetal, donor1, tech_rep1	10071-101I8	18.72	1.44	1.44	1.44	0.00	1.44	0.00	1.44	1.44	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	23.54	6.62	1.47	8.09	0.74	3.68	2.94	3.68	4.41	5.89
dura mater, adult, donor1	10041-101F5	19.74	8.42	8.26	6.19	4.38	3.88	3.63	1.49	4.29	3.22
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	35.31	72.62	9.77	22.65	9.55	8.44	7.11	8.66	3.11	1.78
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	15.19	8.45	2.87	6.73	2.72	3.15	3.73	1.29	0.57	1.00
embryonic pancreas cell line:1B2C6	10604-108F1	16.03	40.08	16.03	3.70	16.03	6.17	1.85	6.78	2.47	2.47
embryonic pancreas cell line:1C3D3	10605-108F2	19.37	39.05	32.69	6.05	20.28	17.56	3.33	9.38	4.54	1.51
embryonic pancreas cell line:1C3IKEI	10606-108F3	17.91	53.72	25.63	7.72	18.22	11.73	3.70	12.04	1.23	3.09
embryonic pancreas cell line:2C6	10603-108E9	18.39	42.03	24.96	6.57	10.51	2.63	1.31	5.25	3.94	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	53.97	83.46	7.37	17.09	16.42	21.79	12.40	23.46	7.71	4.69
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	33.89	72.49	8.88	10.15	14.50	30.27	5.44	18.12	5.26	10.51
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	40.20	18.82	7.72	9.97	6.27	4.18	22.35	7.24	6.11	5.95
epidermoid carcinoma cell line:A431	10426-106D3	26.12	30.35	19.90	6.11	13.23	8.89	4.45	5.00	2.89	1.67
epidermoid carcinoma cell line:Ca Ski	10431-106D8	49.05	28.38	3.74	11.33	5.50	7.81	8.03	7.15	7.92	3.19
epididymis, adult	10197-103E8	10.88	1.88	3.77	2.51	1.47	1.47	1.26	1.88	1.47	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	3.15	22.41	1.57	0.79	5.90	13.37	2.75	3.15	1.18	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	57.27	27.52	68.93	20.84	34.07	13.63	5.77	6.29	8.13	4.72
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	78.24	48.62	88.28	30.61	38.09	17.13	5.71	7.48	10.04	4.53
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	54.67	26.33	57.47	20.28	28.23	15.35	6.05	6.05	8.74	5.27
esophagus, adult, pool1	10015-101C6	23.25	3.29	9.56	5.63	3.82	1.59	3.82	1.38	3.93	3.08
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	14.15	6.39	19.54	4.63	6.51	4.01	6.64	1.75	2.25	0.75
eye - muscle inferior rectus, donor1	10272-104E2	7.24	2.41	4.83	0.00	0.00	4.83	0.00	0.00	4.83	4.83
eye - muscle lateral, donor2	10298-104H1	39.98	4.21	18.94	6.31	0.00	0.00	8.42	0.00	8.42	4.21
eye - muscle medial, donor2	10299-104H2	26.79	2.98	7.44	0.00	0.00	0.00	0.00	1.49	7.44	4.46
eye - muscle superior, donor2	10297-104G9	16.05	1.15	9.17	4.59	2.29	0.00	1.15	1.15	4.59	1.15
eye - vitreous humor, donor1	10268-104D7	8.74	5.83	1.46	4.37	0.00	1.46	7.29	1.46	13.12	7.29
eye, fetal, donor1	10054-101G9	40.68	2.54	7.63	7.12	2.54	0.51	6.36	1.53	4.07	1.78
fibrosarcoma cell line:HT-1080	10758-110E2	5.64	20.64	8.98	1.92	11.54	7.05	0.77	5.00	1.80	0.51
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	11.63	20.89	4.99	4.51	6.65	6.65	2.37	6.89	2.37	0.95
frontal lobe, adult, pool1	10040-101F4	44.94	3.10	1.69	11.35	0.66	0.75	4.50	2.35	11.92	12.85
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	68.16	31.53	8.11	17.71	8.11	7.81	14.41	6.61	6.00	4.80
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	20.30	10.06	4.11	6.77	3.66	3.66	1.19	3.66	3.02	0.91
gall bladder, adult	10198-103E9	16.18	3.14	1.45	5.55	1.45	1.21	2.41	2.17	5.07	3.14
gamma delta positive T cells, donor1	11937-126A2	90.19	16.64	9.13	29.53	7.52	3.76	12.88	5.37	11.81	2.15
gamma delta positive T cells, donor2	11938-126A3	65.36	25.02	9.34	22.04	5.98	4.86	16.06	8.22	11.95	3.36
gastric adenocarcinoma cell line:MKN1	10614-108G2	49.85	26.61	8.24	9.08	9.29	9.93	4.22	3.17	1.90	1.90
gastric adenocarcinoma cell line:MKN45	10612-108F9	47.97	52.80	7.35	8.12	10.25	16.25	3.29	18.57	8.90	6.38
gastric cancer cell line:AZ521	10549-107H9	31.64	44.27	6.23	7.54	11.80	16.40	2.95	19.18	2.46	4.10
gastric cancer cell line:GSS	10560-108A2	25.63	33.86	0.92	11.90	9.15	7.32	2.75	16.47	2.75	7.32
gastrointestinal carcinoma cell line:ECC12	10615-108G3	29.24	55.29	5.03	7.08	8.22	13.02	5.25	6.63	2.28	2.51
giant cell carcinoma cell line:LU65	10487-107B1	65.75	47.39	47.04	23.87	27.42	17.33	3.44	10.90	6.20	3.44
giant cell carcinoma cell line:Lu99B	10433-106E1	27.15	33.17	29.67	7.56	21.13	8.82	1.68	6.30	3.50	1.54
glassy cell carcinoma cell line:HOKUG	10688-109F4	58.11	39.91	9.23	16.21	10.72	11.97	12.22	6.73	3.74	2.24
glioblastoma cell line:A172, tech_rep1	10444-106F3	7.92	5.38	3.48	2.85	3.59	2.96	2.64	1.16	1.37	2.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	6.74	4.77	3.09	2.11	4.07	3.23	2.39	3.65	0.42	1.40
glioblastoma cell line:T98G	10485-107A8	19.87	23.84	29.47	7.06	14.46	7.73	4.53	4.64	3.64	2.10
glioma cell line:GI-1	10413-106B8	31.05	67.07	4.39	8.49	8.49	25.48	5.27	14.06	3.22	1.76
globus pallidus - adult, donor10196	10175-103C4	20.41	0.00	0.00	6.56	0.00	0.00	3.64	4.37	3.64	3.64
globus pallidus, adult, donor10252	10161-103A8	18.80	1.71	0.49	4.15	0.00	0.00	2.69	1.71	5.86	3.91
globus pallidus, adult, donor10258	10367-105F7	30.12	0.00	1.37	4.11	0.00	2.74	2.74	0.00	4.11	12.32
globus pallidus, newborn, donor10223	10364-105F4	18.65	3.20	1.60	9.59	1.07	1.07	2.13	0.53	3.20	4.26
granulocyte macrophage progenitor, donor1	12131-128D7	31.81	12.24	0.00	12.24	0.00	4.89	19.58	4.89	2.45	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	10.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00	10.93
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	0.00	0.00	5.23	5.23	0.00	5.23	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	10.24	17.92	2.56	7.36	2.88	6.72	1.28	2.56	3.52	2.24
hIPS +CCl2, biol_rep1	14383-156B9	33.97	27.09	4.13	4.13	6.43	1.84	5.05	6.43	7.35	0.92
hIPS +CCl2, biol_rep2	14384-156C1	34.75	23.78	2.74	6.40	2.29	4.12	4.12	7.32	2.74	1.83
hIPS +CCl2, biol_rep3	14385-156C2	43.15	15.46	1.93	3.86	1.93	3.86	1.93	11.59	6.44	3.86
hIPS, biol_rep1	14380-156B6	45.99	11.50	0.00	17.25	1.44	1.44	0.00	8.62	8.62	1.44
hIPS, biol_rep2	14381-156B7	30.18	24.69	2.06	2.06	2.06	0.69	4.12	14.40	2.74	2.06
hIPS, biol_rep3	14382-156B8	39.72	7.72	0.00	4.41	0.00	2.21	4.41	2.21	2.21	15.45
hairy cell leukemia cell line:Mo	10712-109I1	15.80	14.65	1.72	2.30	3.16	8.33	3.16	1.72	1.44	1.72
heart - mitral valve, adult	10205-103F7	14.95	2.09	8.37	3.29	1.49	0.00	1.20	0.60	2.09	1.49
heart - pulmonic valve, adult	10206-103F8	22.23	2.61	12.81	4.97	2.35	1.57	2.88	0.78	4.18	3.66
heart - tricuspid valve, adult	10207-103F9	9.16	1.67	9.16	2.50	1.67	0.00	0.00	5.00	1.67	1.67
heart, adult, diseased post-infarction, donor1	10050-101G5	64.28	23.06	13.47	12.04	5.71	8.37	16.73	6.94	7.75	4.49
heart, adult, diseased, donor1	10051-101G6	61.32	6.81	23.85	18.31	4.26	3.41	5.96	2.13	10.22	5.54
heart, adult, pool1	10016-101C7	33.58	4.60	10.35	11.96	0.92	1.61	3.68	1.61	8.74	3.91
heart, fetal, pool1	10046-101G1	97.55	9.65	29.78	27.62	3.29	2.05	12.22	6.57	16.33	7.60
hepatic mesenchymal tumor cell line:LI90	10778-110G4	10.18	22.21	0.31	3.09	2.47	4.32	1.23	7.10	0.93	1.54
hepatoblastoma cell line:HuH-6	10633-108I3	16.65	19.03	3.57	7.14	1.19	5.95	0.00	2.38	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	24.53	16.46	9.06	7.51	7.62	6.85	3.76	4.97	3.31	1.44
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	28.64	14.81	10.32	5.10	7.65	6.07	4.25	4.37	0.97	0.85
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	26.48	17.48	10.61	6.47	9.80	7.98	3.94	4.14	1.92	1.52
hepatoma cell line:Li-7	10484-107A7	64.51	72.62	7.45	27.47	8.12	15.79	3.11	13.01	4.23	2.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	35.18	68.24	11.06	5.13	12.46	12.96	9.75	13.97	3.72	2.61
hippocampus - adult, donor10196	10169-103B7	29.34	2.84	0.95	4.73	0.00	0.95	0.95	0.95	8.52	2.84
hippocampus, adult, donor10252	10153-102I9	41.02	2.04	1.22	6.53	0.41	0.20	6.74	2.86	8.78	11.43
hippocampus, adult, donor10258	10374-105G5	44.82	1.00	1.00	7.97	1.00	0.50	1.00	1.00	6.47	8.47
hippocampus, newborn, donor10223	10363-105F3	14.80	1.06	1.06	6.34	0.35	0.35	2.82	1.41	0.70	4.93
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	53.10	25.02	5.49	16.48	7.32	6.10	17.09	6.71	8.54	5.49
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	28.28	17.08	2.75	6.68	2.95	4.71	6.68	7.07	2.95	2.75
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	31.48	19.04	3.05	12.69	3.81	4.57	8.63	5.33	3.81	3.55
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	18.61	4.51	1.13	2.26	0.00	0.56	2.82	1.69	2.82	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	18.33	3.61	3.10	2.32	2.58	0.77	3.36	1.03	1.81	1.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	19.36	3.42	0.76	4.93	1.14	0.76	4.56	1.90	2.28	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	30.07	20.14	7.59	6.71	5.84	4.67	5.55	7.01	2.04	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	22.19	14.00	4.95	4.95	2.80	4.74	4.52	5.39	1.94	1.08
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	30.86	27.53	10.01	5.84	3.34	6.26	7.09	4.59	1.67	1.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	25.57	6.16	5.92	7.81	3.55	2.84	6.16	3.55	1.42	1.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	20.41	11.09	6.91	4.66	4.34	4.02	6.43	3.70	1.45	1.45
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	20.20	12.12	4.71	5.39	4.04	2.69	8.75	4.71	2.02	2.69
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	31.14	23.63	2.03	7.20	4.07	3.29	7.20	9.86	5.63	2.66
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	28.50	20.14	4.42	7.86	4.91	2.46	8.35	3.93	4.42	2.46
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	28.80	15.71	3.49	13.09	6.98	4.36	7.85	3.49	3.49	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	19.47	4.20	3.05	4.20	1.15	0.95	3.63	1.72	2.48	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	20.50	4.36	2.62	2.62	1.31	0.87	1.31	1.31	2.18	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	25.99	5.50	3.50	4.00	2.00	1.00	4.50	1.50	2.00	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	10.36	3.39	3.39	0.75	0.57	1.70	1.51	0.57	0.75	1.13
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	10.00	4.55	2.73	0.91	1.82	2.27	0.91	2.27	0.45	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	8.46	5.95	3.13	1.25	1.25	0.31	0.31	2.51	0.63	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	14.86	5.55	4.08	2.94	1.80	2.12	4.25	2.94	0.49	0.65
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	13.35	6.68	5.23	2.03	1.16	3.48	1.45	2.03	1.16	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	13.15	9.57	5.08	2.09	4.78	3.89	5.68	3.59	0.60	1.49
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	26.79	30.11	4.25	8.31	2.22	5.17	8.50	9.42	3.88	4.25
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	23.39	25.68	3.71	5.42	4.85	5.14	10.56	10.84	4.56	3.42
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	42.46	33.89	5.31	9.39	4.90	6.94	6.53	11.84	4.08	5.31
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	22.18	8.10	8.80	2.82	2.82	2.11	4.58	2.46	3.17	1.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	17.74	5.07	3.17	2.53	1.90	3.17	3.17	3.17	1.27	1.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	14.83	7.87	1.82	5.45	1.21	3.63	8.47	2.12	1.82	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	19.13	15.51	3.10	0.52	3.62	2.07	4.14	1.03	0.00	1.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	15.28	10.63	6.64	5.98	2.66	1.99	0.66	1.33	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	16.16	9.24	3.59	3.85	3.08	3.08	3.85	1.54	0.77	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	13.80	7.93	4.60	2.56	3.07	2.05	6.90	3.07	1.02	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	17.42	8.33	3.03	1.51	0.76	4.54	4.54	2.27	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	10.42	12.10	2.69	4.03	3.36	2.69	5.38	3.70	1.01	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	25.36	23.91	2.90	5.80	4.59	4.83	5.80	12.80	4.11	2.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	27.63	26.29	4.46	10.25	3.57	6.68	7.58	8.47	4.01	3.57
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	26.34	31.71	2.44	9.76	6.83	3.41	10.24	5.85	4.39	3.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	21.70	5.20	2.14	4.58	1.83	2.75	4.58	2.14	1.53	1.83
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	71.57	16.27	32.53	3.25	9.76	16.27	19.52	0.00	3.25	13.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	20.85	6.29	3.64	8.27	1.65	3.97	4.96	1.32	3.97	1.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	21.89	20.80	3.28	3.28	2.74	2.74	4.93	4.38	1.09	1.64
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	22.44	13.75	3.98	4.34	1.81	2.90	1.81	2.90	1.81	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	18.15	12.10	4.27	1.78	1.07	3.56	4.27	2.49	2.14	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	4.77	4.77	2.39	4.77	0.00	1.19	5.97	2.39	1.19	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	28.57	14.63	5.01	5.82	2.84	5.28	6.23	3.52	1.35	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	12.66	11.05	2.96	2.96	2.42	3.23	2.69	4.04	1.08	0.81
immature langerhans cells, donor1	11904-125F5	81.36	67.80	38.02	15.01	18.40	13.08	112.60	15.98	5.81	1.94
immature langerhans cells, donor2	11905-125F6	63.37	32.48	9.51	13.47	1.58	7.13	45.94	7.92	3.17	0.79
insula, adult, pool1	10039-101F3	43.44	2.74	0.95	12.68	0.38	0.85	3.97	1.04	10.03	11.83
keratoacanthoma cell line:HKA-1	10791-110H8	31.21	11.71	12.36	8.45	9.43	3.90	6.83	5.53	4.55	4.88
kidney, adult, pool1	10017-101C8	18.42	3.10	2.30	4.11	2.10	1.30	3.70	1.20	4.51	1.70
kidney, fetal, pool1	10045-101F9	22.78	3.75	2.05	3.61	1.49	1.34	4.03	1.77	3.47	2.33
large cell lung carcinoma cell line:IA-LM	10509-107D5	39.06	67.46	19.88	11.79	21.59	18.04	2.84	20.74	8.24	5.54
large cell lung carcinoma cell line:NCI-H460	10839-111E2	24.33	26.27	27.10	7.33	9.95	7.88	0.97	3.73	4.84	2.35
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	23.12	61.66	4.95	5.32	10.83	14.50	2.02	11.19	6.06	2.02
left atrium, adult, donor1	10079-102A7	21.25	5.99	7.63	2.18	2.18	3.81	1.63	1.09	1.63	1.63
left ventricle, adult, donor1	10078-102A6	20.23	5.06	8.09	5.06	0.51	1.52	2.02	2.02	2.53	5.06
leiomyoblastoma cell line:G-402	10721-110A1	21.34	17.78	25.72	7.39	12.31	7.93	16.42	4.10	5.20	3.56
leiomyoma cell line:10964C	10569-108B2	3.23	1.08	1.08	0.00	0.00	0.72	1.44	0.36	0.36	1.08
leiomyoma cell line:15242A	10570-108B3	2.17	3.26	11.41	1.63	2.72	1.63	0.54	3.26	0.54	0.00
leiomyoma cell line:15425	10571-108B4	5.58	4.13	3.40	1.46	1.70	1.21	3.16	1.46	1.46	1.46
leiomyosarcoma cell line:Hs 5.T	10722-110A2	19.05	12.70	19.05	12.70	6.35	0.00	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	13.59	13.59	3.14	5.23	0.00	1.05	4.18	4.18	1.05	3.14
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	32.23	48.76	6.26	8.03	12.04	18.54	2.72	12.51	3.31	2.72
liposarcoma cell line:KMLS-1	10782-110G8	3.28	2.66	0.16	1.25	0.47	0.16	0.31	1.25	0.47	0.00
liposarcoma cell line:SW 872	10726-110A6	11.82	8.89	1.22	2.44	2.44	2.92	3.41	2.44	1.34	1.10
liver, adult, pool1	10018-101C9	10.70	2.27	0.65	4.05	2.27	0.65	0.32	0.49	0.65	0.49
liver, fetal, pool1	10086-102B5	3.76	0.94	0.94	0.00	0.94	0.94	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	27.71	3.50	1.60	7.73	1.17	2.19	3.79	2.62	5.83	10.35
locus coeruleus, adult, donor10252	10165-103B3	27.68	4.80	1.66	4.43	1.11	0.92	2.95	1.48	10.89	7.01
locus coeruleus, adult, donor10258	10375-105G6	29.34	3.67	2.82	4.23	0.85	1.13	4.80	2.54	4.80	6.49
locus coeruleus, newborn, donor10223	10362-105F2	18.51	3.36	3.79	6.31	0.42	2.52	4.21	0.84	1.68	3.79
lung adenocarcinoma cell line:A549	10499-107C4	39.72	39.17	10.66	9.83	16.47	14.81	2.21	10.38	1.66	2.91
lung adenocarcinoma cell line:PC-14	10408-106B3	7.58	3.45	4.14	1.38	2.07	0.69	1.38	2.07	1.38	2.07
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	33.09	15.16	1.32	6.99	1.85	5.27	3.03	6.72	3.30	2.11
lung, adult, pool1	10019-101D1	13.94	3.07	0.95	3.66	2.01	0.59	1.06	1.42	2.36	1.06
lung, fetal, donor1	10068-101I5	15.70	3.14	3.14	5.14	1.43	1.71	0.86	0.57	3.42	1.43
lung, right lower lobe, adult, donor1	10075-102A3	11.00	1.83	2.75	1.37	1.37	0.46	0.92	0.46	2.29	1.37
lymph node, adult, donor1	10077-102A5	43.08	10.41	3.31	6.15	2.84	2.37	8.99	3.79	2.37	2.37
lymphangiectasia cell line:DS-1	10727-110A7	25.21	28.27	8.33	4.82	13.15	5.26	3.95	10.30	2.85	1.75
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	35.92	10.56	1.51	3.17	2.57	5.28	7.70	3.32	4.68	3.77
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	71.36	85.80	26.33	33.13	24.64	22.09	13.59	20.39	4.25	3.40
mature adipocyte, donor1	12231-129F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	0.62	0.21	0.00	0.00	0.00	0.00	0.21	0.00	0.00	0.00
mature adipocyte, donor3	12233-129G1	0.00	0.24	0.24	0.00	0.24	0.00	0.24	0.00	0.00	0.00
mature adipocyte, donor4	12234-129G2	0.53	0.00	0.00	0.00	0.00	0.00	0.26	0.00	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	57.18	50.03	3.10	20.73	11.91	17.39	2.62	21.44	4.77	8.10
medial frontal gyrus - adult, donor10196	10170-103B8	49.63	2.26	1.13	9.02	2.26	2.26	3.38	2.26	6.77	9.02
medial frontal gyrus, adult, donor10252	10150-102I6	24.83	1.66	0.74	7.91	0.74	0.18	2.02	2.21	8.09	8.64
medial frontal gyrus, adult, donor10258	10368-105F8	40.35	2.86	1.59	8.26	0.32	2.86	2.22	0.32	6.35	8.90
medial frontal gyrus, newborn, donor10223	10352-105E1	49.90	4.26	2.56	17.91	0.43	0.85	8.10	2.99	2.99	9.81
medial temporal gyrus - adult, donor10196	10183-103D3	38.98	2.19	0.17	7.59	0.34	1.01	3.71	2.87	5.57	7.26
medial temporal gyrus, adult, donor10252	10156-103A3	22.71	1.06	1.70	6.37	0.00	0.00	2.33	1.91	7.64	8.49
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	21.19	0.00	1.93	9.63	1.93	0.00	1.93	0.00	3.85	11.56
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	71.77	0.00	14.35	0.00	0.00	0.00	0.00	0.00	0.00	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	33.74	3.95	3.23	10.77	2.51	0.72	5.03	2.15	6.10	9.33
medulla oblongata - adult, donor10196	10174-103C3	34.40	4.54	1.95	4.54	1.95	1.30	7.14	0.00	11.68	6.49
medulla oblongata, adult, donor10252	10155-103A2	45.67	4.18	6.35	10.84	0.93	0.62	12.07	6.19	16.25	7.28
medulla oblongata, adult, pool1	10038-101F2	51.26	6.53	5.63	11.67	2.53	2.86	11.26	3.51	15.26	14.53
medulla oblongata, newborn, donor10223	10361-105F1	17.36	3.12	1.39	5.90	1.04	2.43	3.47	1.04	2.43	6.25
medulloblastoma cell line:D283 Med	10838-111E1	17.05	16.16	1.77	4.21	1.55	3.32	0.89	5.31	1.33	0.89
medulloblastoma cell line:ONS-76	10759-110E3	19.20	21.52	1.59	4.89	4.89	6.60	4.52	6.48	5.99	3.55
melanoma cell line:COLO 679	10514-107E1	11.36	16.39	2.30	2.59	3.45	5.03	1.44	4.31	0.86	1.58
melanoma cell line:G-361	10465-106H6	1.90	1.63	0.54	0.54	0.81	2.17	0.00	0.81	0.54	0.54
meningioma cell line:HKBMM	10691-109F7	8.86	10.13	8.68	1.45	3.80	3.62	0.72	1.81	0.54	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	65.21	1.76	1.76	9.69	4.41	5.29	4.41	0.88	6.17	6.17
merkel cell carcinoma cell line:MS-1	10844-111E7	60.66	13.48	0.78	11.41	2.33	5.18	21.77	4.15	11.41	11.67
mesenchymal precursor cell - adipose, donor1	11747-123G1	3.07	2.92	1.07	0.61	0.61	0.61	0.31	1.07	0.31	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	4.73	16.91	2.54	0.55	3.09	6.18	1.27	3.64	0.73	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	4.14	3.73	2.07	0.41	2.90	0.00	0.00	0.83	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	0.84	1.26	0.00	0.00	0.00	0.14	0.00	0.14	0.42	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	1.16	1.54	0.39	0.00	0.19	0.00	0.19	0.58	0.77	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	0.00	2.08	0.00	0.00	0.69	0.00	0.69	0.69	1.39	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	15.62	24.54	15.96	4.81	11.16	3.26	2.06	5.66	3.43	1.03
mesenchymal precursor cell - cardiac, donor2	11753-123G7	10.93	9.89	3.80	1.50	3.22	3.11	1.61	2.53	1.96	1.27
mesenchymal precursor cell - cardiac, donor3	11754-123G8	4.38	3.45	3.32	0.53	2.92	0.93	1.06	0.93	0.40	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	4.59	3.11	1.76	2.03	1.35	0.81	0.54	0.41	0.27	0.41
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	9.67	10.95	4.13	1.71	3.98	2.99	2.42	2.28	1.56	1.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	12.84	25.03	3.62	3.95	2.63	7.25	1.65	3.62	1.32	0.99
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	7.20	8.30	1.52	0.83	1.80	1.66	0.83	3.04	0.83	1.11
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	8.03	3.49	8.73	2.79	3.84	2.44	0.35	2.09	0.00	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	6.53	4.70	1.22	1.43	0.82	1.02	0.41	0.82	0.41	1.22
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	12.58	9.35	2.88	1.44	2.88	4.31	2.16	3.95	0.72	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	3.41	4.66	0.62	0.31	0.52	0.72	0.21	1.24	0.83	1.14
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	4.10	7.30	1.37	1.82	3.65	1.14	0.46	0.23	0.91	1.37
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	8.81	7.13	2.94	1.68	3.78	3.36	3.36	1.68	2.52	1.26
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	1.64	1.34	0.15	0.45	0.30	0.15	0.45	0.90	0.00	0.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	12.95	26.78	7.53	2.45	6.48	5.34	2.10	3.06	2.36	1.58
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	5.15	6.26	0.37	0.37	1.10	1.84	0.00	4.05	1.47	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	8.58	14.02	2.86	2.58	3.72	2.00	1.43	4.01	1.72	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	12.63	8.42	2.53	2.95	1.68	2.11	6.32	1.26	0.84	2.95
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	10.05	8.68	7.76	1.83	5.94	2.74	3.65	2.28	1.37	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	10.74	12.28	6.65	1.28	6.39	4.60	4.09	1.53	0.77	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	13.09	12.56	4.97	3.14	4.71	7.33	2.36	2.88	1.31	1.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	12.02	6.78	2.77	2.16	5.24	6.47	1.23	1.54	2.16	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	7.53	8.00	5.18	1.88	7.77	6.83	3.53	2.12	1.18	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	6.77	7.11	5.08	3.72	5.08	4.40	2.37	1.35	1.02	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	9.04	13.75	7.86	3.14	3.14	6.29	1.57	3.14	1.57	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	7.41	6.49	7.41	2.32	4.17	6.95	1.39	2.32	1.39	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	48.30	0.00	48.30	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	14.42	10.67	6.06	3.17	4.61	6.92	2.60	2.31	2.60	1.73
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	13.16	8.92	5.58	2.68	3.57	5.80	2.23	1.34	0.67	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	12.74	9.13	5.29	1.68	4.33	4.09	3.36	1.68	0.72	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	24.20	21.27	5.87	3.67	5.13	3.67	2.93	2.20	2.20	2.93
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	10.07	9.73	7.05	3.69	5.03	2.69	4.03	1.01	0.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	7.78	11.46	2.46	2.05	4.91	6.55	2.87	1.23	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	13.75	9.02	2.15	2.15	3.01	5.58	2.58	1.72	2.15	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	5.47	16.41	2.73	0.00	2.73	0.00	0.00	5.47	0.00	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	15.49	10.33	0.00	5.16	10.33	5.16	0.00	10.33	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	12.02	10.07	4.87	2.60	2.27	3.57	2.60	2.92	0.65	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	8.73	11.64	5.82	1.45	1.45	2.91	4.36	0.00	1.45	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	11.19	7.46	6.40	3.73	4.26	7.46	1.60	2.67	3.20	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	12.27	13.90	4.91	2.45	0.82	6.54	4.91	4.09	0.82	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	12.05	8.16	2.72	3.11	3.89	5.05	2.33	1.94	0.78	1.55
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	14.69	6.30	2.10	0.00	2.10	8.39	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	7.95	8.94	3.97	1.99	1.99	3.97	0.99	2.98	1.99	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	0.00	0.00	14.30	0.00	0.00	0.00	0.00	0.00	4.77	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	13.05	8.30	2.37	3.56	2.96	4.74	0.59	2.96	0.00	2.96
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	8.53	6.09	6.09	3.66	2.44	4.87	1.22	1.22	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	27.05	0.00	0.00	0.00	0.00	0.00	27.05	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	5.07	10.13	4.43	3.17	3.17	5.70	1.90	1.90	1.27	1.90
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	7.59	8.97	3.10	2.07	0.34	1.38	0.69	2.41	0.69	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	8.60	4.30	2.15	2.15	0.00	0.00	0.00	4.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	0.00	7.98	0.00	0.00	3.99	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	3.44	6.89	6.89	0.00	0.00	6.89	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	4.07	4.48	1.22	2.44	1.63	2.04	0.41	2.44	0.81	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	7.15	3.18	2.38	1.59	3.18	2.38	0.79	2.38	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	3.54	2.36	0.00	1.77	0.59	0.00	0.00	1.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	4.36	4.99	0.62	0.31	0.00	0.00	0.00	0.31	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	2.67	2.67	1.34	0.00	0.00	1.34	1.34	1.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	1.18	0.00	0.00	0.00	0.00	0.00	1.18	0.00	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	0.00	0.00	2.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	3.44	0.69	0.00	1.38	0.00	0.00	0.00	0.00	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	0.49	1.48	0.00	0.00	0.49	0.00	0.49	0.49	0.49	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	3.36	1.12	0.00	2.24	0.00	0.00	0.00	0.00	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	1.27	1.91	0.00	0.00	0.00	0.64	0.64	0.64	1.27	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	1.61	1.21	0.00	1.21	0.00	0.00	0.00	0.00	0.40	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	0.00	2.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	0.00	0.00	0.00	2.53	0.00	0.00	0.00	1.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	16.39	12.14	1.21	4.86	1.21	2.43	0.00	0.00	0.61	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	13.56	9.04	0.00	13.56	0.00	4.52	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	15.65	9.88	0.00	9.06	1.65	3.29	0.00	3.29	1.65	3.29
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	6.15	5.95	1.19	2.18	0.40	0.99	0.40	1.39	0.40	0.99
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	3.89	3.24	0.65	1.30	0.32	0.32	0.65	1.30	0.97	0.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	9.17	1.02	0.00	2.04	0.00	1.02	1.02	0.00	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	3.09	4.64	0.77	0.77	1.55	0.77	0.77	3.09	0.77	1.55
mesothelioma cell line:ACC-MESO-1	10493-107B7	18.90	21.50	4.72	8.27	10.87	7.80	1.42	7.32	3.31	1.89
mesothelioma cell line:ACC-MESO-4	10494-107B8	12.28	12.97	5.79	3.94	3.71	4.63	4.17	5.10	2.32	2.55
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	8.55	17.09	8.55	0.00	4.27	8.55	8.55	0.00	0.00	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	6.78	8.12	8.43	2.88	5.75	2.16	3.39	1.64	1.03	0.31
mesothelioma cell line:Mero-25	10850-111F4	22.92	51.75	19.74	7.49	12.71	14.98	5.22	6.35	2.04	0.91
mesothelioma cell line:Mero-41	10851-111F5	12.47	12.47	4.65	5.13	5.87	7.33	3.67	3.42	1.96	2.44
mesothelioma cell line:Mero-48a	10852-111F6	8.64	6.86	1.77	1.77	1.11	2.44	1.99	2.21	0.66	1.33
mesothelioma cell line:Mero-82	10853-111F7	27.86	46.52	12.09	7.36	13.14	17.08	5.52	3.15	1.84	1.58
mesothelioma cell line:Mero-83	10854-111F8	12.94	10.89	2.89	2.55	2.21	4.60	4.09	1.70	2.04	1.70
mesothelioma cell line:Mero-84	10855-111F9	2.02	5.56	4.30	0.76	4.55	2.53	0.25	0.51	2.27	1.01
mesothelioma cell line:Mero-95	10856-111G1	13.66	15.94	4.97	5.18	6.63	7.45	2.48	2.90	3.93	3.52
mesothelioma cell line:NCI-H2052	10847-111F1	16.90	19.55	8.45	6.96	5.96	5.96	5.80	3.15	4.47	0.50
mesothelioma cell line:NCI-H226	10846-111E9	11.95	19.37	8.51	3.26	7.96	7.78	3.80	3.98	1.99	2.53
mesothelioma cell line:NCI-H2452	10848-111F2	19.47	19.13	26.48	6.32	12.47	11.62	7.69	2.73	3.76	2.39
mesothelioma cell line:NCI-H28	10845-111E8	24.43	17.56	16.29	6.36	12.98	11.45	6.11	5.09	4.33	4.58
mesothelioma cell line:No36	10857-111G2	24.14	12.72	8.48	6.52	4.57	3.26	4.24	2.28	4.57	2.61
mesothelioma cell line:ONE58	10858-111G3	18.97	27.64	26.28	9.75	14.90	6.77	5.69	2.98	4.06	1.90
migratory langerhans cells, donor1	11901-125F2	11.52	4.80	3.45	3.26	4.61	4.99	1.54	3.07	1.92	1.15
migratory langerhans cells, donor2	11902-125F3	16.61	7.57	1.22	2.32	4.27	5.62	2.44	3.42	1.34	2.08
migratory langerhans cells, donor3	11903-125F4	21.36	6.28	5.74	3.41	7.54	4.13	2.69	3.23	2.69	2.87
mixed mullerian tumor cell line:HTMMT	10689-109F5	16.98	23.83	6.53	5.55	3.59	5.22	1.63	3.92	2.29	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	12.50	7.84	3.18	3.18	3.39	1.48	1.91	2.97	2.76	0.85
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	37.32	42.62	5.76	6.22	7.83	8.98	7.37	8.52	4.61	2.07
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	17.32	7.99	7.04	3.04	5.52	3.43	3.81	4.19	1.14	0.95
myelodysplastic syndrome cell line:SKM-1	10772-110F7	12.75	12.01	2.96	5.91	3.70	2.96	0.37	5.17	0.92	0.92
myeloma cell line:PCM6	10474-106I6	47.04	67.60	7.51	13.64	13.84	32.42	3.36	13.84	5.73	5.73
myxofibrosarcoma cell line:MFH-ino	10600-108E6	13.70	7.10	0.51	6.59	1.01	3.55	0.00	6.59	1.52	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	12.55	3.53	3.53	1.96	3.14	0.59	1.77	0.39	0.59	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	44.46	44.68	13.48	10.14	18.27	16.27	4.23	5.57	5.46	2.12
nasal epithelial cells, donor1, tech_rep2	12226-129F3	41.99	54.93	17.43	13.83	16.18	18.83	6.03	4.56	7.21	2.43
nasal epithelial cells, donor2	12227-129F4	37.54	43.61	19.87	8.28	23.74	18.77	9.38	5.52	9.38	4.42
neuroblastoma cell line:CHP-134	10508-107D4	96.17	205.44	4.60	36.12	10.58	38.88	11.04	49.23	14.49	6.44
neuroblastoma cell line:NB-1	10539-107G8	54.07	25.82	4.30	13.28	6.17	12.72	5.05	8.23	7.86	7.11
neuroblastoma cell line:NBsusSR	10607-108F4	31.42	31.00	0.21	11.18	1.05	1.27	1.05	11.18	3.59	0.42
neuroblastoma cell line:NH-12	10555-107I6	77.52	45.28	8.20	19.38	7.45	7.64	7.45	11.37	13.98	4.85
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	15.66	2.61	0.24	6.41	0.00	0.00	1.66	1.90	1.19	1.90
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	17.90	3.96	0.00	3.33	0.00	0.79	0.48	2.69	2.69	3.48
neuroectodermal tumor cell line:TASK1	10774-110F9	2.01	1.81	0.20	0.40	0.00	0.20	0.20	1.41	0.20	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	19.07	8.90	0.00	8.26	0.64	0.64	1.91	5.72	1.27	1.27
neurofibroma cell line:Hs 53.T	10729-110A9	9.58	13.04	5.06	2.40	3.73	2.13	0.53	7.45	1.33	0.53
neutrophil PMN, donor1	12133-128D9	29.75	0.00	0.00	14.87	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	0.00	0.00	13.28	0.00	0.00	13.28	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	9.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	91.16	131.41	26.89	17.25	33.49	18.77	10.49	31.12	6.26	5.75
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	55.24	16.01	8.81	12.01	11.21	15.21	13.61	4.00	13.61	8.01
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	14.43	16.67	8.66	3.53	4.49	2.56	5.13	4.49	1.60	3.21
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	16.82	18.13	9.72	4.99	3.94	4.20	4.99	5.52	2.36	2.63
nucleus accumbens, adult, pool1	10037-101F1	43.31	1.78	0.47	9.28	0.47	0.75	5.62	1.78	9.66	11.44
occipital cortex - adult, donor10196	10172-103C1	53.57	0.00	0.00	12.36	2.06	2.06	0.00	4.12	0.00	10.30
occipital cortex, adult, donor10252	10163-103B1	32.47	4.56	1.88	7.25	0.00	0.00	3.76	3.49	7.51	6.71
occipital cortex, newborn, donor10223	10355-105E4	44.04	5.10	3.28	14.56	0.73	0.73	7.28	1.46	4.73	9.46
occipital lobe, adult, donor1	10076-102A4	56.42	3.15	2.62	7.08	0.52	1.57	5.25	2.36	8.40	13.12
occipital lobe, fetal, donor1	10073-102A1	99.98	4.72	3.43	27.46	1.29	0.86	4.72	9.01	8.58	20.60
occipital pole, adult, pool1	10036-101E9	37.84	2.76	1.26	8.91	0.63	1.42	3.00	2.29	7.02	12.22
olfactory region, adult	10195-103E6	33.82	0.96	2.48	3.82	0.57	0.38	4.20	0.96	7.64	6.50
optic nerve, donor1	10277-104E7	10.01	4.00	6.00	4.00	0.00	0.00	0.00	0.00	0.00	4.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	44.20	22.10	12.87	14.92	8.54	7.86	7.75	4.78	2.62	1.03
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	32.29	17.86	9.34	5.77	8.79	4.95	3.57	5.50	5.77	2.06
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	41.15	25.06	5.08	9.48	5.76	6.26	4.23	4.23	2.71	1.69
oral squamous cell carcinoma cell line:SAS	10544-107H4	42.85	58.79	11.20	9.01	14.90	18.25	4.62	12.82	12.01	3.70
osteoclastoma cell line:Hs 706.T	10704-109H2	13.52	18.23	2.35	3.82	3.23	2.06	1.18	3.82	1.18	2.65
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	13.08	48.59	3.74	2.80	5.61	16.82	0.93	18.69	4.67	4.67
osteosarcoma cell line:HS-Os-1	10558-107I9	13.36	13.78	4.45	5.09	4.24	4.45	1.48	4.45	2.12	0.85
ovary, adult, pool1	10020-101D2	11.88	7.51	3.93	5.15	2.71	2.45	1.40	4.28	3.49	3.14
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	11.37	8.25	0.37	2.20	0.55	1.47	1.65	4.58	2.38	0.55
pancreas, adult, donor1	10049-101G4	29.16	12.23	7.53	7.53	12.23	6.58	0.94	3.76	6.58	1.88
pancreatic carcinoma cell line:NOR-P1	10698-109G5	22.92	23.20	4.75	8.67	4.47	5.87	3.91	6.71	1.12	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	29.81	51.11	51.45	13.12	16.18	6.64	8.52	4.77	5.28	2.56
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	42.55	24.34	2.32	8.78	4.47	10.27	4.64	5.96	4.80	3.31
paracentral gyrus, adult, pool1	10035-101E8	51.89	3.48	1.46	11.44	0.64	1.92	4.67	2.93	9.98	13.00
parietal cortex, adult, donor10258	10373-105G4	35.23	3.67	0.00	8.81	0.00	0.73	0.73	0.00	7.34	5.87
parietal lobe - adult, donor10196	10171-103B9	39.50	2.82	0.94	7.52	0.94	0.00	2.82	2.82	7.52	9.40
parietal lobe, adult, donor10252	10157-103A4	32.21	2.00	1.43	8.84	0.57	0.57	2.28	4.28	10.83	7.98
parietal lobe, adult, pool1	10034-101E7	45.03	3.00	1.41	10.49	0.62	0.79	4.49	2.11	10.40	10.40
parietal lobe, fetal, donor1	10072-101I9	73.71	3.88	1.94	37.82	0.00	1.94	5.82	8.73	12.61	10.67
parietal lobe, newborn, donor10223	10356-105E5	41.50	6.36	1.87	15.33	0.00	1.12	4.86	1.12	3.36	10.47
parotid gland, adult	10199-103F1	6.78	1.85	1.85	1.23	1.85	1.23	0.00	0.62	0.62	1.23
penis, adult	10200-103F2	19.34	3.76	11.82	4.30	4.83	1.61	3.22	2.69	2.69	2.15
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	10.97	2.79	1.86	2.79	1.86	0.93	0.00	2.23	3.16	3.90
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	53.32	62.50	9.76	15.44	11.51	18.94	7.58	17.19	10.20	2.91
pineal gland - adult, donor10196	10179-103C8	28.38	3.23	2.58	7.74	0.00	3.23	0.65	0.65	6.45	14.19
pineal gland, adult, donor10252	10160-103A7	39.09	1.18	7.11	10.66	5.33	1.18	1.18	1.78	8.88	10.07
pineal gland, adult, donor10258	10377-105G8	21.95	0.63	0.63	9.41	0.63	0.00	1.88	0.63	5.64	6.27
pituitary gland - adult, donor10196	10180-103C9	66.78	14.17	4.05	16.19	5.06	3.04	7.08	8.09	10.12	7.08
pituitary gland, adult, donor10252	10162-103A9	81.83	21.89	7.30	26.58	10.94	5.21	3.13	9.90	26.06	14.59
pituitary gland, adult, donor10258	10378-105G9	27.24	3.40	3.40	13.62	1.70	1.70	3.40	0.00	5.96	8.51
placenta, adult, pool1	10021-101D3	68.69	28.49	9.03	11.61	10.64	9.89	40.96	4.30	1.40	0.54
plasma cell leukemia cell line:ARH-77	10840-111E3	44.23	33.37	2.91	6.89	3.44	5.69	7.95	8.61	2.52	0.93
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	1.71	2.65	0.62	0.78	0.16	1.25	0.31	0.47	0.00	0.31
pons, adult, pool1	10033-101E6	49.66	6.37	4.22	12.14	1.98	3.96	5.59	3.01	15.06	17.56
postcentral gyrus, adult, pool1	10032-101E5	44.55	2.96	1.05	9.85	1.05	0.35	3.75	2.18	10.90	14.30
promyelocytes/myelocytes PMC, donor1	12132-128D8	10.46	4.18	2.09	4.18	0.00	2.09	4.18	2.09	0.00	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	5.51	0.00	0.00	5.51	5.51	0.00	0.00	0.00	5.51	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	23.45	17.77	5.83	6.41	10.34	8.74	3.79	7.14	2.62	3.20
prostate cancer cell line:PC-3	10439-106E7	50.64	58.63	9.80	12.34	8.89	18.15	13.43	9.44	15.06	9.62
prostate, adult, pool1	10022-101D4	12.88	2.00	1.81	3.81	2.09	1.18	1.09	0.82	3.08	2.18
putamen, adult, donor10196	10176-103C5	35.65	0.94	0.47	6.14	0.00	0.47	1.42	1.65	4.96	5.43
putamen, adult, donor10252	10152-102I8	27.45	0.00	0.00	1.96	0.00	0.00	0.00	0.00	3.92	9.80
putamen, adult, donor10258, tech_rep1	10372-105G3	29.51	8.74	3.28	7.65	0.00	0.00	6.56	2.19	9.84	3.28
putamen, adult, donor10258, tech_rep2	10372-105G3	24.89	0.48	0.48	7.25	0.00	0.00	0.97	0.48	4.83	6.28
putamen, newborn, donor10223	10365-105F5	37.48	4.50	3.00	10.50	0.00	1.50	9.00	1.50	4.50	1.50
rectal cancer cell line:TT1TKB	10469-106I1	28.80	45.09	17.17	8.15	21.82	15.71	6.11	9.02	1.16	0.58
rectum, fetal, donor1	10067-101I4	15.30	5.56	5.56	5.56	2.78	0.00	5.56	6.95	2.78	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	34.77	13.99	14.20	8.90	10.18	6.36	11.45	6.57	3.82	5.30
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	23.20	6.21	3.73	6.21	3.73	1.66	2.90	2.90	4.56	1.66
retina, adult, pool1	10030-101E3	19.88	1.69	3.58	3.78	1.39	1.29	2.39	0.60	6.16	4.37
retinoblastoma cell line:Y79	10475-106I7	34.29	11.95	7.27	7.53	9.09	5.20	9.09	3.12	1.82	2.08
rhabdomyosarcoma cell line:KYM-1	10787-110H4	20.16	15.49	4.43	2.83	5.41	9.34	7.13	5.53	3.93	2.95
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	44.15	136.38	10.40	10.40	17.43	18.84	18.00	32.90	7.87	4.78
sacrococcigeal teratoma cell line:HTST	10695-109G2	10.61	21.22	8.34	2.27	3.79	1.52	2.27	9.09	4.55	0.76
salivary acinar cells, donor1	11771-123I7	30.91	29.46	28.65	7.93	8.42	10.20	5.83	4.05	3.72	1.13
salivary acinar cells, donor2	11772-123I8	25.06	11.84	15.97	7.16	2.75	3.58	3.30	2.20	4.82	3.30
salivary acinar cells, donor3	11773-123I9	34.43	9.93	4.63	7.28	1.32	2.65	7.28	2.65	0.66	1.32
salivary gland, adult, pool1	10093-102C3	21.16	4.58	1.14	6.86	1.72	0.57	0.57	0.57	2.29	6.86
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	13.24	25.80	5.23	4.47	8.18	6.58	1.43	8.68	1.85	2.53
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	10.46	23.98	4.11	2.70	6.94	6.23	0.71	9.05	3.17	1.41
seminal vesicle, adult	10201-103F3	44.97	17.99	9.52	12.17	10.05	19.05	10.05	4.76	7.94	8.99
serous adenocarcinoma cell line:JHOS-2	10639-108I9	39.84	15.30	19.43	8.50	10.93	6.56	15.06	6.07	7.77	3.16
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	17.36	9.81	2.77	3.77	3.77	1.76	1.26	3.27	0.75	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	11.04	3.01	10.04	5.02	7.02	1.00	1.00	0.00	2.01	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	48.09	20.69	18.00	12.89	7.92	6.72	16.79	4.03	5.10	2.69
signet ring carcinoma cell line:Kato III	10436-106E4	108.76	95.39	23.54	25.20	22.55	33.60	19.89	14.81	11.94	6.52
signet ring carcinoma cell line:NUGC-4	10483-107A6	48.38	13.42	28.77	14.84	18.84	9.81	13.81	4.64	8.26	4.64
skeletal muscle - soleus muscle, donor1	10282-104F3	58.87	4.97	20.57	7.09	5.67	4.26	3.55	0.71	0.71	1.42
skeletal muscle, adult, pool1	10023-101D5	19.67	4.32	24.71	3.84	4.44	1.68	1.68	0.24	0.72	0.72
skeletal muscle, fetal, donor1	10066-101I3	3.02	2.01	3.02	0.00	0.00	0.00	2.01	0.00	1.01	1.01
skin, adult, donor1	10074-102A2	20.36	6.79	6.79	6.79	6.79	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	21.46	2.52	5.68	6.94	1.26	0.00	1.89	1.89	6.31	4.42
small cell cervical cancer cell line:HCSC-1	10800-110I8	75.38	21.68	3.34	20.34	5.00	10.01	10.01	8.67	9.67	6.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	38.14	25.22	4.73	8.51	5.04	10.09	6.62	4.41	7.88	8.20
small cell lung carcinoma cell line:DMS 144	10841-111E4	36.04	15.03	3.85	7.32	1.93	5.98	14.65	8.67	6.17	7.90
small cell lung carcinoma cell line:LK-2	10541-107H1	134.99	148.84	54.72	45.99	62.96	57.52	14.34	19.12	14.34	8.90
small cell lung carcinoma cell line:NCI-H82	10842-111E5	64.66	39.41	7.40	16.73	4.99	10.46	11.26	12.22	13.51	5.47
small cell lung carcinoma cell line:WA-hT	10562-108A4	113.75	91.74	18.31	31.38	15.91	24.84	35.96	15.04	22.66	10.46
small intestine, adult, pool1	10024-101D6	22.10	3.22	2.99	4.90	2.03	1.19	3.94	2.03	3.70	3.34
small intestine, fetal, donor1	10064-101I1	19.66	1.97	4.67	5.41	1.23	0.98	2.46	1.23	2.95	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	55.39	23.08	66.16	9.75	17.44	7.18	20.00	2.05	6.15	3.08
smooth muscle, adult, pool1	10048-101G3	10.08	1.55	2.07	3.36	1.03	0.52	0.52	2.33	2.07	1.29
somatostatinoma cell line:QGP-1	10781-110G7	117.66	148.48	22.78	24.93	25.19	36.72	25.46	32.70	13.94	6.70
spinal cord - adult, donor10196	10181-103D1	45.65	5.74	2.52	6.88	0.92	2.52	13.99	3.21	7.34	10.55
spinal cord, adult, donor10252	10159-103A6	76.09	9.46	3.55	13.80	1.18	1.18	9.86	9.86	10.25	7.10
spinal cord, adult, donor10258	10369-105F9	85.09	4.84	9.69	13.14	1.38	0.00	19.37	1.38	20.75	6.92
spinal cord, fetal, donor1	10056-101H2	37.81	3.05	5.49	9.76	0.00	1.83	7.32	2.44	7.32	7.93
spinal cord, newborn, donor10223	10359-105E8	24.80	3.67	4.59	11.48	2.30	1.38	6.89	1.38	3.21	5.97
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	15.83	19.57	5.97	2.99	4.78	6.42	1.19	8.36	1.64	1.79
spleen, adult, pool1	10025-101D7	29.96	8.04	1.98	6.94	2.86	1.10	5.73	3.08	2.09	1.21
spleen, fetal, pool1	10044-101F8	26.94	6.44	1.83	4.85	1.59	1.59	6.91	1.67	2.86	1.43
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	61.49	27.95	5.90	16.35	6.11	9.63	32.30	9.01	4.66	2.48
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	54.49	42.34	7.03	13.86	11.20	18.80	5.70	8.73	1.90	0.57
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	100.29	42.63	21.32	23.41	11.53	11.18	33.55	9.78	12.23	7.34
squamous cell carcinoma cell line:T3M-5	10616-108G4	46.52	79.36	2.74	12.51	7.43	13.68	3.91	21.50	5.47	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	58.19	26.68	3.94	14.63	7.09	10.92	5.74	5.29	6.53	1.35
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	16.10	10.17	5.93	4.24	5.51	2.12	0.42	1.27	2.12	2.54
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	16.50	29.61	9.31	6.35	15.23	8.88	2.96	8.04	2.12	2.12
stomach, fetal, donor1	10062-101H8	14.95	5.34	0.00	4.27	1.07	2.14	1.07	3.20	4.27	0.00
submaxillary gland, adult	10202-103F4	23.93	1.71	7.98	5.13	2.28	1.71	4.56	0.57	2.85	2.85
substantia nigra - adult, donor10196	10178-103C7	108.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	29.91	2.70	2.08	5.19	0.21	0.21	4.36	3.53	3.32	2.91
substantia nigra, adult, donor10258	10371-105G2	40.35	2.07	2.59	7.76	0.00	1.03	2.07	1.55	7.24	9.83
substantia nigra, newborn, donor10223	10358-105E7	9.89	2.83	0.71	7.77	0.00	1.41	2.12	2.83	3.53	4.95
synovial sarcoma cell line:HS-SY-II	10441-106E9	31.41	11.92	4.59	10.32	3.21	3.44	15.59	4.81	5.04	4.81
temporal lobe, adult, pool1	10031-101E4	28.06	1.61	0.51	7.54	0.93	0.59	3.39	1.61	5.26	9.92
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	64.82	0.71	0.71	19.23	0.71	0.71	3.56	4.27	6.41	8.55
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	54.06	2.20	1.76	13.19	0.00	0.00	2.64	2.20	5.27	6.15
tenocyte, donor1	11763-123H8	1.75	1.05	0.70	0.00	0.35	0.00	0.35	0.00	0.70	0.00
tenocyte, donor2	11765-123I1	1.91	0.38	0.76	0.00	0.00	0.38	0.00	0.00	0.00	0.38
tenocyte, donor3	11768-123I4	0.00	0.74	0.74	0.37	0.00	0.00	0.37	0.00	0.00	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	6.29	4.59	1.19	1.70	2.04	2.38	1.02	2.21	1.02	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	1.39	1.08	0.31	0.15	0.31	0.31	0.31	0.00	0.15	0.00
teratocarcinoma cell line:PA-1	10807-111A6	20.15	24.49	5.11	4.49	5.73	5.11	3.10	10.69	2.94	1.55
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	35.67	48.24	22.72	7.24	18.92	14.85	7.49	11.04	2.54	2.29
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	45.76	62.40	9.45	10.59	13.24	18.53	5.29	11.72	5.29	5.67
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	81.14	55.19	10.80	11.56	14.94	15.05	3.16	14.94	4.80	3.60
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	19.87	21.50	3.26	4.89	8.14	11.73	2.28	3.91	0.98	0.33
testis, adult, pool1	10026-101D8	5.37	1.18	1.50	1.29	0.64	0.86	0.75	0.43	0.54	0.64
testis, adult, pool2	10096-102C6	3.16	2.71	0.45	0.45	0.45	0.00	0.45	0.45	0.45	0.00
thalamus - adult, donor10196	10168-103B6	45.26	3.31	4.42	3.31	0.00	3.31	3.31	0.00	5.52	5.52
thalamus, adult, donor10252	10154-103A1	28.29	1.88	1.09	6.56	0.00	0.31	2.66	2.50	8.13	3.91
thalamus, adult, donor10258, tech_rep1	10370-105G1	61.58	3.08	0.00	9.24	0.00	1.54	3.08	4.62	15.40	13.86
thalamus, adult, donor10258, tech_rep2	10370-105G1	25.69	5.76	2.31	4.78	1.81	1.98	2.96	1.98	4.61	6.92
thalamus, newborn, donor10223	10366-105F6	28.19	11.51	5.75	10.93	1.15	2.88	6.90	4.03	2.88	8.05
throat, adult	10209-103G2	22.22	2.00	7.24	5.24	1.75	1.25	1.75	1.00	2.25	2.25
throat, fetal, donor1	10061-101H7	28.95	3.05	3.35	6.09	2.13	0.91	2.13	1.83	3.35	1.52
thymic carcinoma cell line:Ty-82	10803-111A2	4.37	0.40	0.20	0.40	0.20	0.20	0.79	0.20	0.40	0.60
thymus, adult, pool1	10027-101D9	61.94	4.37	4.08	19.88	2.29	1.49	6.86	2.19	15.21	8.85
thymus, fetal, pool1	10043-101F7	70.86	6.65	3.95	18.18	2.08	2.39	6.86	3.32	14.55	8.94
thyroid carcinoma cell line:KHM-5M	10776-110G2	27.26	47.73	4.52	6.65	7.98	15.82	5.32	7.05	3.46	1.20
thyroid carcinoma cell line:TCO-1	10783-110G9	27.80	48.47	4.75	3.91	9.50	13.55	1.68	10.90	4.75	2.65
thyroid, adult, pool1	10028-101E1	23.79	6.35	3.36	5.41	2.71	2.99	0.75	2.71	2.24	2.05
thyroid, fetal, donor1	10060-101H6	35.33	6.06	2.37	5.01	0.79	3.16	5.01	1.85	3.43	3.69
tongue epidermis (fungiform papillae), donor1	10288-104F9	24.64	6.16	15.40	3.08	3.08	0.00	0.00	0.00	3.08	3.08
tongue, adult	10203-103F5	27.91	3.49	14.88	6.28	3.72	1.63	3.26	0.70	3.02	1.16
tongue, fetal, donor1	10059-101H5	38.62	1.58	10.64	8.28	1.97	1.58	3.55	0.00	1.97	3.55
tonsil, adult, pool1	10047-101G2	52.99	9.72	6.01	11.02	4.41	3.31	8.11	3.91	7.91	3.31
trachea, adult, pool1	10029-101E2	25.11	6.05	3.35	7.28	2.86	2.37	2.62	2.70	3.44	2.70
trachea, fetal, donor1	10058-101H4	24.24	6.54	16.16	3.85	2.31	0.77	1.54	1.54	1.92	2.31
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	13.11	24.09	3.90	2.83	6.73	9.92	3.19	4.96	1.42	1.77
transitional-cell carcinoma cell line:5637	10418-106C4	48.53	35.76	43.06	12.87	17.63	7.70	19.55	5.78	3.44	1.72
transitional-cell carcinoma cell line:JMSU1	10492-107B6	23.97	68.32	30.24	5.95	27.42	18.49	2.98	13.79	6.89	5.01
tridermal teratoma cell line:HGRT	10694-109G1	1.90	5.71	3.81	0.00	0.00	0.00	0.00	0.00	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	45.20	19.30	56.46	11.26	17.78	6.35	4.66	4.74	4.83	2.37
umbilical cord, fetal, donor1	10057-101H3	33.38	8.35	12.52	16.69	0.00	4.17	8.35	6.26	8.35	2.09
uterus, adult, pool1	10100-102D1	19.28	5.46	6.65	5.46	4.27	0.51	2.56	1.02	4.10	3.41
uterus, fetal, donor1	10055-101H1	7.68	0.51	0.51	1.02	0.00	0.51	2.05	2.05	1.54	1.02
vagina, adult	10204-103F6	11.63	2.58	3.88	3.23	1.29	0.00	0.65	1.29	0.65	0.00
vein, adult	10191-103E2	35.95	6.80	2.41	5.92	0.88	1.75	4.16	1.32	5.70	1.97
xeroderma pigentosum b cell line:XPL 17	10563-108A5	23.23	12.82	3.74	1.60	1.34	2.67	3.47	4.54	2.67	0.80